{
  "meta": {
    "title": "17_Pediatrics_Fast_Track_Tnd_2025",
    "url": "https://brainandscalpel.vercel.app/17-pediatrics-fast-track-tnd-2025-12b989cc.html",
    "scrapedAt": "2025-11-30T06:47:19.629Z"
  },
  "questions": [
    {
      "id": 59344,
      "choices": [
        {
          "id": 205276,
          "text": "Adjusting the mask seal"
        },
        {
          "id": 205277,
          "text": "Repositioning the head"
        },
        {
          "id": 205278,
          "text": "Opening the mouth with jaw thrust"
        },
        {
          "id": 205279,
          "text": "Starting chest compressions"
        }
      ],
      "text": "A 3-day-old neonate in the NICU receives PPV for respiratory distress. After 30 seconds, HR remains 70/min. The medical team considers their next intervention. Which action is NOT appropriate at this time?",
      "unique_key": "Q1369620",
      "question_audio": null,
      "question_video": null,
      "map_id": 34243840,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D)\r\n\r\nExplanation: Chest compressions are only indicated when HR falls below 60/min despite effective ventilation. At HR of 70/min, clinicians should first optimize ventilation using the MRSOPA steps (Mask adjustment, Reposition, Suction, Open mouth, Pressure increase, Alternative airway) before considering compressions.\r\n",
      "correct_choice_id": 205279,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59345,
      "choices": [
        {
          "id": 205280,
          "text": "Chest compressions"
        },
        {
          "id": 205281,
          "text": "Insertion of umbilical artery catheter"
        },
        {
          "id": 205282,
          "text": "Administration of 100% oxygen"
        },
        {
          "id": 205283,
          "text": "Endotracheal intubation"
        }
      ],
      "text": "A neonate undergoing resuscitation in the NICU has a heart rate of 40/minute despite 30 seconds of PPV. As the team continues resuscitation efforts, which intervention should NOT be performed at this critical moment?",
      "unique_key": "Q5910864",
      "question_audio": null,
      "question_video": null,
      "map_id": 34540858,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nExplanation: During critical neonatal resuscitation with HR <60, priority actions include chest compressions, increasing oxygen to 100%, and securing the airway via intubation. An umbilical venous catheter (UVC), not arterial (UAC), is indicated for emergency medication administration. UAC insertion is time-consuming and inappropriate during active resuscitation.\r\n",
      "correct_choice_id": 205281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59346,
      "choices": [
        {
          "id": 205284,
          "text": "0.5 ml/kg"
        },
        {
          "id": 205285,
          "text": "0.7 ml/kg"
        },
        {
          "id": 205286,
          "text": "0.9 ml/kg"
        },
        {
          "id": 205287,
          "text": "1.0 ml/kg"
        }
      ],
      "text": "A term newborn with severe perinatal asphyxia is undergoing resuscitation in the delivery room. After intubation and chest compressions, the heart rate remains at 40 beats per minute. An umbilical venous catheter is being placed, but the team leader decides epinephrine administration is urgent and opts for the endotracheal route while IV access is established. What is the correct endotracheal dose of epinephrine in ml/kg according to the NRP 8th Edition guidelines?",
      "unique_key": "Q5230233",
      "question_audio": null,
      "question_video": null,
      "map_id": 34392590,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D)\r\n\r\nExplanation: The NRP 8th Edition recommends an endotracheal epinephrine dose of 1.0 ml/kg (equivalent to 0.1 mg/kg of the 1:10,000 concentration). This higher volume is needed for effective drug delivery through the endotracheal route compared to the intravenous dose, as absorption is less predictable via the pulmonary vasculature.\r\n",
      "correct_choice_id": 205287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59347,
      "choices": [
        {
          "id": 205288,
          "text": "Synchronized cardioversion at 0.5 J/kg"
        },
        {
          "id": 205289,
          "text": "Defibrillation at 2 J/kg"
        },
        {
          "id": 205290,
          "text": "Defibrillation at 4 J/kg"
        },
        {
          "id": 205291,
          "text": "Defibrillation at 10 J/kg"
        }
      ],
      "text": "An unconscious school-aged child is found on a busy Delhi street by first responders. CPR is initiated immediately after confirming cardiac arrest. The emergency medical team arrives with a defibrillator and connects the child to cardiac monitoring. The ECG is shown here. The team prepares for immediate electrical intervention. What is the most appropriate next step in managing this pediatric cardiac arrest with confirmed ventricular fibrillation?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/4(667).png\" alt=\"Question Image\"></p>",
      "unique_key": "Q5133351",
      "question_audio": null,
      "question_video": null,
      "map_id": 34235355,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nExplanation: For pediatric pulseless ventricular fibrillation, immediate defibrillation at 2 J/kg is indicated as the first-line electrical therapy. Synchronized cardioversion is inappropriate for pulseless rhythms. Higher energy doses (4 J/kg) are considered for subsequent shocks if initial defibrillation is unsuccessful, while 10 J/kg exceeds recommended pediatric dosing guidelines",
      "correct_choice_id": 205289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59348,
      "choices": [
        {
          "id": 205292,
          "text": "IV adenosine 0.1 mg/kg rapid push"
        },
        {
          "id": 205293,
          "text": "IV amiodarone 5 mg/kg over 60 minutes"
        },
        {
          "id": 205294,
          "text": "Synchronized cardioversion at 0.5-1 J/kg"
        },
        {
          "id": 205295,
          "text": "IV esmolol infusion at 500 mcg/kg/min"
        }
      ],
      "text": "A 4-year-old previously healthy girl presents to the emergency department with acute onset tachycardia, pallor, and irritability. Vital signs show heart rate of 220 bpm, blood pressure 70/40 mmHg, respiratory rate 40/min with mild retractions, and delayed capillary refill of 4 seconds. ECG confirms supraventricular tachycardia. Despite two attempts at vagal maneuvers, the rhythm persists. What is the most appropriate immediate management for this patient?",
      "unique_key": "Q9570732",
      "question_audio": null,
      "question_video": null,
      "map_id": 34884978,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nExplanation: This child has SVT with cardiovascular compromise evidenced by hypotension and poor perfusion. While adenosine is first-line for stable SVT, synchronized cardioversion (0.5-1 J/kg) is indicated when hemodynamic instability is present. Cardioversion offers rapid rhythm conversion in unstable patients when seconds matter, unlike medications which may have delayed effect.\r\n",
      "correct_choice_id": 205294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59349,
      "choices": [
        {
          "id": 205296,
          "text": "0.05 mg/kg (maximum 3 mg)"
        },
        {
          "id": 205297,
          "text": "0.1 mg/kg (maximum 6 mg)"
        },
        {
          "id": 205298,
          "text": "0.2 mg/kg (maximum 12 mg)"
        },
        {
          "id": 205299,
          "text": "0.3 mg/kg (maximum 18 mg)"
        }
      ],
      "text": "A 7-year-old boy presents to pediatric urgent care with palpitations and dizziness for 45 minutes. Vital signs show heart rate 210 bpm, blood pressure 100/70 mmHg, and normal respiratory effort. ECG demonstrates narrow complex tachycardia consistent with SVT. The child is alert, well-perfused, and IV access has been established. What is the correct initial dose of adenosine according to current PALS guidelines?",
      "unique_key": "Q2792128",
      "question_audio": null,
      "question_video": null,
      "map_id": 34230674,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nExplanation: Per PALS guidelines, the initial dose of adenosine for pediatric SVT is 0.1 mg/kg with a maximum first dose of 6 mg. Adenosine should be administered as a rapid IV push followed by immediate saline flush. If unsuccessful, a second dose of 0.2 mg/kg (maximum 12 mg) can be given, followed by a third dose if needed.\r\n",
      "correct_choice_id": 205297,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59350,
      "choices": [
        {
          "id": 205300,
          "text": "At 15 months of age, a child should receive MMR-2, Varicella-2, and PCV booster"
        },
        {
          "id": 205301,
          "text": "At 18-19 months of age, a child should receive HepA-2 and Varicella-2"
        },
        {
          "id": 205302,
          "text": "At 4-6 years of age, a child should receive DTP-B2, IPV-B2, and MMR-3"
        },
        {
          "id": 205303,
          "text": "At 10-12 years of age, a child should receive HPV and Tdap"
        }
      ],
      "text": "According to the Indian Academy of Pediatrics (IAP) 2021 Immunization Schedule, which of the following statements is INCORRECT?",
      "unique_key": "Q4776082",
      "question_audio": null,
      "question_video": null,
      "map_id": 34669242,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A)  \r\n\r\nAt 15 months of age, a child should receive MMR-2, Varicella-2, and PCV booster\r\n\r\nAccording to the IAP 2021 Immunization Schedule, the correct vaccination at 15 months includes:\r\n\r\nMMR-2 (Measles, Mumps, Rubella - second dose)\r\n\r\nVaricella-1 (first dose of Varicella vaccine, not the second dose)\r\n\r\nPCV booster (Pneumococcal Conjugate Vaccine booster)",
      "correct_choice_id": 205300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59351,
      "choices": [
        {
          "id": 205304,
          "text": "Hepatitis A"
        },
        {
          "id": 205305,
          "text": "MMR-2 (Measles, Mumps, Rubella - second dose)"
        },
        {
          "id": 205306,
          "text": "Tdap (Tetanus, diphtheria, acellular pertussis)"
        },
        {
          "id": 205307,
          "text": "Varicella-2 (second dose)"
        }
      ],
      "text": "A 10-year-old child is brought to your clinic for routine vaccination. According to the Indian Academy of Pediatrics (IAP) 2021 Immunization Schedule, which of the following vaccines should be administered at this age?",
      "unique_key": "Q9744541",
      "question_audio": null,
      "question_video": null,
      "map_id": 34084731,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nTdap (Tetanus, diphtheria, acellular pertussis)\r\n\r\nAccording to the IAP 2021 Immunization Schedule, the recommended vaccines for children aged 10-12 years include:\r\n\r\nTdap vaccine - This is a booster dose of the tetanus, diphtheria, and acellular pertussis vaccine that provides continued protection against these diseases. The Tdap vaccine is specifically formulated for adolescents and adults with reduced antigen content compared to DTaP given to younger children.\r\n\r\nThe HPV (Human Papillomavirus) vaccine is also recommended in this age group, though it wasn't among the options presented.",
      "correct_choice_id": 205306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59352,
      "choices": [
        {
          "id": 205308,
          "text": "Nasal Continuous Positive Airway Pressure (CPAP)"
        },
        {
          "id": 205309,
          "text": "Bag and mask ventilation"
        },
        {
          "id": 205310,
          "text": "Supplemental oxygen via free flow in room air"
        },
        {
          "id": 205311,
          "text": "Immediate endotracheal intubation and mechanical ventilation"
        }
      ],
      "text": "You are called to the labor room for the delivery of an extremely premature infant. A neonate is born at 28 weeks gestation with a birth weight of 500 grams. Upon initial assessment, the infant demonstrates signs of respiratory distress with a Silverman score of 4 (moderate respiratory distress). The infant has spontaneous breathing but shows intercostal retractions, xiphoid retractions, and nasal flaring. Heart rate is 140 bpm, and oxygen saturation is 82% in room air. What is the most appropriate first-line intervention for this extremely preterm infant with respiratory distress in the labor room?",
      "unique_key": "Q6540051",
      "question_audio": null,
      "question_video": null,
      "map_id": 34683748,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A)  \r\n\r\nNasal Continuous Positive Airway Pressure (CPAP)\r\n\r\nDetailed Explanation\r\n\r\nThe correct management for this extremely preterm infant (28 weeks, 500 grams) with respiratory distress (Silverman score of 4) is to initiate Nasal Continuous Positive Airway Pressure (CPAP).\r\n\r\nWhy Nasal CPAP is the correct choice:\r\n\r\nPhysiological rationale: Extremely preterm infants have several challenges with respiratory function:\r\n\r\nUnderdeveloped alveoli with insufficient surfactant production\r\n\r\nWeak respiratory muscles\r\n\r\nHighly compliant chest wall\r\n\r\nTendency for alveolar collapse (atelectasis)\r\n\r\nCPAP helps by:\r\n\r\nMaintaining positive end-expiratory pressure (PEEP)\r\n\r\nPreventing alveolar collapse\r\n\r\nReducing work of breathing\r\n\r\nPreserving endogenous surfactant\r\n\r\nStabilizing the chest wall\r\n\r\nImproving functional residual capacity\r\n\r\nEvidence-based approach: Multiple randomized controlled trials have demonstrated that early CPAP in very preterm infants with respiratory distress can:\r\n\r\nReduce the need for subsequent mechanical ventilation\r\n\r\nDecrease the incidence of bronchopulmonary dysplasia (BPD)\r\n\r\nPotentially reduce mortality\r\n\r\nCurrent guidelines: The Neonatal Resuscitation Program (NRP) and European Consensus Guidelines recommend consideration of CPAP for preterm infants with respiratory distress who have spontaneous breathing.",
      "correct_choice_id": 205308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59353,
      "choices": [
        {
          "id": 205312,
          "text": "3"
        },
        {
          "id": 205313,
          "text": "4"
        },
        {
          "id": 205314,
          "text": "5"
        },
        {
          "id": 205315,
          "text": "6"
        }
      ],
      "text": "You are called to assess a 32-week preterm infant who is 4 hours old. On examination, you observe the following: The infant's chest and abdomen move synchronously during breathing There is moderate sternal retraction during inspiration There is minimal to no xiphoid retraction The infant shows moderate nasal flaring during inspiration You notice audible grunting with a stethoscope but not without it What is the Silverman-Anderson score for this infant?",
      "unique_key": "Q5056434",
      "question_audio": null,
      "question_video": null,
      "map_id": 34548780,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nDetailed Explanation\r\n\r\nThe Silverman-Anderson score is used to assess respiratory distress in neonates by evaluating five parameters, with each scored from 0-2 (where 0 represents normal and 2 represents severe abnormality):\r\n\r\nChest movement:\r\n\r\nScore 0: Synchronous chest and abdominal movement\r\n\r\nScore 1: Lag on inspiration\r\n\r\nScore 2: See-saw respirations (paradoxical breathing)\r\n\r\n→ This infant has synchronous movement = 0 points\r\n\r\nIntercostal retractions:\r\n\r\nScore 0: None\r\n\r\nScore 1: Minimal\r\n\r\nScore 2: Marked\r\n\r\n→ This infant has moderate sternal retraction = 1 point\r\n\r\nXiphoid retractions:\r\n\r\nScore 0: None\r\n\r\nScore 1: Minimal\r\n\r\nScore 2: Marked\r\n\r\n→ This infant has minimal to no xiphoid retraction = 1 point\r\n\r\nNasal flaring:\r\n\r\nScore 0: None\r\n\r\nScore 1: Minimal\r\n\r\nScore 2: Marked\r\n\r\n→ This infant has moderate nasal flaring = 1 point\r\n\r\nExpiratory grunting:\r\n\r\nScore 0: None\r\n\r\nScore 1: Audible with stethoscope only\r\n\r\nScore 2: Audible without stethoscope\r\n\r\n→ This infant has grunting audible only with stethoscope = 1 point\r\n\r\nTotal Silverman-Anderson Score: 0 + 1 + 1 + 1 + 1 = 4\r\n\r\nA score of 4 indicates moderate respiratory distress. The clinical implications of this score suggest the need for respiratory support, likely in the form of nasal CPAP, close monitoring of vital signs, blood gas analysis, and consideration of surfactant therapy depending on oxygen requirements and clinical progression.",
      "correct_choice_id": 205313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59354,
      "choices": [
        {
          "id": 205316,
          "text": "3"
        },
        {
          "id": 205317,
          "text": "4"
        },
        {
          "id": 205318,
          "text": "5"
        },
        {
          "id": 205319,
          "text": "6"
        }
      ],
      "text": "You are managing a 34-week preterm infant in the NICU who is now 2 hours old. The following clinical findings are noted during your assessment: Respiratory rate of 72 breaths per minute Mild intercostal retractions No audible grunting Minimal cyanosis that improves with supplemental oxygen (FiO₂ 0.35) On auscultation, air entry is slightly decreased throughout both lung fields Based on the Downe scoring system, what is this infant's respiratory distress score?",
      "unique_key": "Q7746217",
      "question_audio": null,
      "question_video": null,
      "map_id": 34046935,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nDetailed Explanation\r\n\r\nThe Downe score is another commonly used tool to assess respiratory distress in neonates. It evaluates five parameters, each scored from 0-2, with higher scores indicating more severe distress:\r\n\r\nRespiratory rate:\r\n\r\nScore 0: < 60 breaths per minute\r\n\r\nScore 1: 60-80 breaths per minute\r\n\r\nScore 2: > 80 breaths per minute\r\n\r\n→ This infant has a respiratory rate of 72 breaths per minute = 1 point\r\n\r\nRetractions:\r\n\r\nScore 0: None\r\n\r\nScore 1: Mild\r\n\r\nScore 2: Moderate to severe\r\n\r\n→ This infant has mild intercostal retractions = 1 point\r\n\r\nGrunting:\r\n\r\nScore 0: None\r\n\r\nScore 1: Audible with stethoscope\r\n\r\nScore 2: Audible without stethoscope\r\n\r\n→ This infant has no audible grunting = 0 points\r\n\r\nCyanosis:\r\n\r\nScore 0: None\r\n\r\nScore 1: Disappears with oxygen supplementation\r\n\r\nScore 2: Persists despite oxygen supplementation\r\n\r\n→ This infant has cyanosis that improves with oxygen = 1 point\r\n\r\nAir entry (breath sounds):\r\n\r\nScore 0: Good, equal bilaterally\r\n\r\nScore 1: Decreased but audible\r\n\r\nScore 2: Barely audible or absent\r\n\r\n→ This infant has slightly decreased air entry = 1 point\r\n\r\nTotal Downe Score: 1 + 1 + 0 + 1 + 1 = 4",
      "correct_choice_id": 205317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59355,
      "choices": [
        {
          "id": 205320,
          "text": "Embryonic, Canalicular, Pseudoglandular, Saccular, Alveolar"
        },
        {
          "id": 205321,
          "text": "Embryonic, Pseudoglandular, Canalicular, Saccular, Alveolar"
        },
        {
          "id": 205322,
          "text": "Embryonic, Canalicular, Pseudoglandular, Alveolar, Saccular"
        },
        {
          "id": 205323,
          "text": "Pseudoglandular, Embryonic, Canalicular, Saccular, Alveolar"
        }
      ],
      "text": "You are a neonatologist asked to consult with expectant parents at 23 weeks' gestation. The couple—both research scientists—have concerns about their baby's potential viability if born prematurely. They specifically want to understand lung development in relation to premature birth outcomes. During your consultation, you need to explain the sequential phases of normal lung development to help them understand why pulmonary insufficiency is a critical factor in determining viability at this gestational age. In your explanation of normal lung development to these parents, which of the following represents the correct chronological sequence of developmental phases?",
      "unique_key": "Q8532592",
      "question_audio": null,
      "question_video": null,
      "map_id": 34453788,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Embryonic, Pseudoglandular, Canalicular, Saccular, Alveolar Detailed Explanation The correct sequence of lung development phases is Embryonic &rarr; Pseudoglandular &rarr; Canalicular &rarr; Saccular &rarr; Alveolar. Understanding this developmental timeline is crucial when counseling parents about premature birth at 23 weeks&#39; gestation. Developmental Phases in Detail: 1. Embryonic Phase (0-7 weeks&#39; gestation) The respiratory diverticulum (lung bud) appears as an outgrowth from the ventral wall of the foregut around day 22 Primary bronchi develop by day 26-28 By the end of this phase, the major airways (trachea and main bronchi) are established The pulmonary arteries begin to form alongside the developing airways 2. Pseudoglandular Phase (7-17 weeks&#39; gestation) Named for the gland-like appearance of the developing lung tissue Formation of the bronchial tree through 16-25 generations of dichotomous branching Development of conducting airways down to terminal bronchioles No gas exchange capability exists yet Cartilage formation around the airways begins Epithelial differentiation initiates 3. Canalicular Phase (17-27 weeks&#39; gestation) Critical phase for viability in premature infants Respiratory bronchioles and primitive alveolar ducts form Pulmonary capillary network develops in close proximity to the cuboidal epithelium Epithelial cells begin to differentiate into type I (thin squamous cells for gas exchange) and type II pneumocytes (surfactant production) By 24 weeks, some surfactant production begins, though insufficient for adequate function The air-blood barrier begins to thin, allowing for potential gas exchange 4. Saccular Phase (28-36 weeks&#39; gestation) Terminal sacs (primitive alveoli) form from terminal bronchioles Continued thinning of the interstitium separating capillaries from airspaces Increased surfactant production Further maturation of the air-blood barrier Significant increase in gas exchange surface area This phase explains why infants born after 28 weeks have substantially better respiratory outcomes 5. Alveolar Phase (36 weeks&#39; gestation to childhood) True alveoli begin to form through secondary septation Continued multiplication of alveoli (from ~20-50 million at birth to ~300-500 million in adulthood) Microvascular maturation continues Alveolarization continues through early childhood (approximately 8 years) Clinical Relevance for a 23-Week Fetus: At 23 weeks&#39; gestation, the fetal lungs are in the late Canalicular phase. This has several important implications: Structural limitations: The lungs have primitive respiratory bronchioles but very few terminal sacs, severely limiting the surface area available for gas exchange. Surfactant deficiency: Type II pneumocytes are just beginning to produce surfactant, but quantities are insufficient. This leads to poor lung compliance, alveolar collapse, and respiratory distress syndrome. Thick air-blood barrier: The interstitium between developing capillaries and airspaces is still relatively thick, impeding efficient gas exchange. Immature capillary network: The pulmonary vascular bed is underdeveloped, limiting the efficiency of gas exchange and increasing the risk of pulmonary hypertension. Risk of bronchopulmonary dysplasia (BPD): Mechanical ventilation of these immature lungs can disrupt normal development, leading to chronic lung disease.</p>\r\n",
      "correct_choice_id": 205321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59356,
      "choices": [
        {
          "id": 205324,
          "text": "Continue nasal CPAP and observe for 24 hours before considering surfactant"
        },
        {
          "id": 205325,
          "text": "Perform INSURE (INtubation, SURfactant administration, Extubation to CPAP) technique"
        },
        {
          "id": 205326,
          "text": "Intubate and place on conventional mechanical ventilation with surfactant administration"
        },
        {
          "id": 205327,
          "text": "Administer surfactant via LISA (Less Invasive Surfactant Administration) technique without intubation"
        }
      ],
      "text": "A male infant is born at 30 weeks gestation with a birth weight of 1250 grams. The pregnancy was complicated by premature rupture of membranes 24 hours prior to delivery. The infant has moderate respiratory distress with a Silverman-Anderson score of 5, requiring FiO₂ of 0.70 on nasal CPAP to maintain oxygen saturations of 90-95%. Chest X-ray shows diffuse ground glass appearance with air bronchograms consistent with Respiratory Distress Syndrome (RDS). What is the most appropriate next step in the management of this infant?",
      "unique_key": "Q6113274",
      "question_audio": null,
      "question_video": null,
      "map_id": 34917014,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Perform INSURE (INtubation, SURfactant administration, Extubation to CPAP) technique Detailed Explanation The INSURE technique is the most appropriate management strategy for this 30-week preterm infant with moderate RDS requiring significant oxygen supplementation (FiO₂ 0.40) on CPAP. The INSURE approach consists of: INtubation SURfactant administration Extubation to CPAP Why INSURE is appropriate in this case: Evidence-based criteria for surfactant administration: The European Consensus Guidelines recommend early surfactant for preterm infants with RDS requiring FiO₂ &gt; 0.30 on CPAP This infant requires FiO₂ 0.40, meeting criteria for surfactant therapy Benefits of INSURE compared to other options: Reduces duration of mechanical ventilation Decreases incidence of bronchopulmonary dysplasia (BPD) Lowers risk of air leak syndromes Improves surfactant distribution compared to less invasive techniques Clinical indicators supporting INSURE: Moderate respiratory distress (Silverman-Anderson score of 5) Radiographic evidence of RDS Significant oxygen requirement Gestational age suggesting immature lungs with surfactant deficiency</p>\r\n",
      "correct_choice_id": 205325,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59357,
      "choices": [
        {
          "id": 205328,
          "text": "Immediate endotracheal intubation"
        },
        {
          "id": 205329,
          "text": "Bag and mask ventilation"
        },
        {
          "id": 205330,
          "text": "Insertion of an orogastric tube"
        },
        {
          "id": 205331,
          "text": "Umbilical venous catheterization"
        }
      ],
      "text": "A full-term newborn male is delivered via cesarean section after prenatal diagnosis of left-sided congenital diaphragmatic hernia (CDH) on antenatal ultrasound at 20 weeks. The infant has moderate respiratory distress with visible scaphoid abdomen and barrel-shaped chest. Breath sounds are absent on the left side with heart sounds shifted to the right. Which of the following interventions is contraindicated in the initial stabilization of this infant with congenital diaphragmatic hernia?",
      "unique_key": "Q7659999",
      "question_audio": null,
      "question_video": null,
      "map_id": 34446468,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Bag and mask ventilation Detailed Explanation Bag and mask ventilation is contraindicated in the initial management of an infant with congenital diaphragmatic hernia (CDH) due to several important physiological considerations. Why bag and mask ventilation is contraindicated in CDH: Gas distension of the GI tract: Bag-mask ventilation forces air into the stomach and intestines In CDH, abdominal contents (stomach, intestines) are already herniated into the chest Additional gas distension further compresses the hypoplastic lung, worsening respiratory compromise Increased pulmonary vascular resistance: Gaseous distension of the gut causes additional compression of pulmonary vasculature This exacerbates pulmonary hypertension, which is already a major complication in CDH Compromised venous return: Increased intrathoracic pressure from both the herniated viscera and gas-filled intestines Reduced venous return leads to decreased cardiac output and hemodynamic instability Prevention of effective ventilation: Air preferentially enters the path of least resistance (GI tract rather than hypoplastic lungs) This results in ineffective oxygenation and ventilation despite resuscitation efforts</p>\r\n",
      "correct_choice_id": 205329,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59358,
      "choices": [
        {
          "id": 205332,
          "text": "Hyperkalemia"
        },
        {
          "id": 205333,
          "text": "Hyponatremia"
        },
        {
          "id": 205334,
          "text": "Hypomagnesemia"
        },
        {
          "id": 205335,
          "text": "Hyperphosphatemia"
        }
      ],
      "text": "A 3-hour-old term infant (4.2kg) born to a mother with poorly controlled gestational diabetes presents with irritability, jitteriness, and focal limb movements. Physical exam reveals laryngospasm. ECG shows prolonged QT interval. Blood glucose is 75 mg/dL. Calcium is low at 7.2 mg/dL despite treatment. Which additional electrolyte abnormality should be suspected?",
      "unique_key": "Q9410619",
      "question_audio": null,
      "question_video": null,
      "map_id": 34118515,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Hypomagnesemia Explanation: Infants of diabetic mothers commonly develop hypocalcemia that may be refractory to calcium supplementation due to underlying hypomagnesemia. Magnesium deficiency inhibits parathyroid hormone secretion and action. Clinical features include jitteriness, irritability, seizures, and prolonged QT interval despite normal glucose levels. Hypomagnesemia must be corrected before calcium levels normalize.</p>\r\n",
      "correct_choice_id": 205334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59359,
      "choices": [
        {
          "id": 205336,
          "text": "Hypoglycemia"
        },
        {
          "id": 205337,
          "text": "Hypercalcemia"
        },
        {
          "id": 205338,
          "text": "Polycythemia"
        },
        {
          "id": 205339,
          "text": "Hyperbilirubinemia"
        }
      ],
      "text": "A full-term 4.8kg infant born to a mother with Type 1 diabetes is admitted to NICU with tachypnea and grunting. Initial labs show glucose of 32 mg/dL, hematocrit 68%, and total bilirubin 9.2 mg/dL at 12 hours of life. On exam, the infant appears plethoric with a ruddy complexion. Which of the following is NOT typically associated with infants of diabetic mothers?",
      "unique_key": "Q6545494",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985810,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Hypercalcemia Explanation: Infants of diabetic mothers typically experience hypocalcemia (not hypercalcemia), hypoglycemia, polycythemia, hyperbilirubinemia, and respiratory distress syndrome. These complications result from maternal hyperglycemia causing fetal hyperinsulinemia, which leads to macrosomia, increased erythropoiesis, delayed lung maturation, and rapid glucose consumption after birth.</p>\r\n",
      "correct_choice_id": 205337,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59360,
      "choices": [
        {
          "id": 205340,
          "text": "Neural tube defects and cleft palate"
        },
        {
          "id": 205341,
          "text": "Caudal regression syndrome and cardiac defects"
        },
        {
          "id": 205342,
          "text": "Duodenal atresia and limb reduction defects"
        },
        {
          "id": 205343,
          "text": "Renal agenesis and gastrointestinal anomalies"
        }
      ],
      "text": "A prenatal ultrasound at 20 weeks for a 31-year-old G2P1 woman with pregestational diabetes (HbA1c 9.2%) reveals a fetus with sacral agenesis, femoral hypoplasia, and a ventricular septal defect. The patient asks about the relationship between her diabetes and these findings. Which constellation of anomalies is characteristic of diabetic embryopathy?",
      "unique_key": "Q6650454",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985042,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Caudal regression syndrome and cardiac defects Explanation: Pregestational diabetes with poor glycemic control during organogenesis increases risk of congenital anomalies 2-4 fold. Caudal regression syndrome (sacral agenesis with or without femoral hypoplasia) is relatively specific to diabetic embryopathy, occurring 200-400 times more frequently in infants of diabetic mothers. Cardiac defects, particularly ventricular septal defects and conotruncal abnormalities, are also common manifestations.RetryClaude can make mistakes. Please double-check responses.</p>\r\n",
      "correct_choice_id": 205341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59361,
      "choices": [
        {
          "id": 205344,
          "text": "Cardiac defects occur at similar rates in diabetic and non-diabetic pregnancies"
        },
        {
          "id": 205345,
          "text": "Neural tube defects are the most common anomaly specific to diabetic embryopathy"
        },
        {
          "id": 205346,
          "text": "Caudal regression syndrome occurs 200-400 times more frequently in diabetic pregnancies"
        },
        {
          "id": 205347,
          "text": "Most diabetic embryopathy anomalies develop during the third trimester"
        },
        {
          "id": 205348,
          "text": "Preconception glycemic control has minimal impact on anomaly risk"
        }
      ],
      "text": "You're consulted on a 32-year-old G1P0 woman with Type 1 diabetes since age 15. Her preconception HbA1c was 10.2%, and she didn't receive prenatal care until 16 weeks. Fetal anatomy ultrasound at 20 weeks reveals sacral agenesis with absent lower lumbar vertebrae, bilateral femoral hypoplasia, and a complex cardiac defect including transposition of great arteries. The patient is distraught, asking whether her diabetes contributed to these findings and about the prognosis. Which statement regarding diabetic embryopathy is most accurate?",
      "unique_key": "Q6439865",
      "question_audio": null,
      "question_video": null,
      "map_id": 34602727,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nCaudal regression syndrome occurs 200-400 times more frequently in diabetic pregnancies\r\n\r\nExplanation: Diabetic embryopathy results from hyperglycemia during organogenesis (3-7 weeks). This patient's poor glycemic control and late prenatal care significantly increased risk. While cardiac defects and neural tube defects are more common in diabetic pregnancies, caudal regression syndrome (sacral agenesis with or without femoral hypoplasia) has the strongest association, occurring 200-400 times more frequently in diabetic pregnancies. Preconception optimization of glycemic control (HbA1c <6.5%) can reduce congenital anomaly risk to near-baseline.",
      "correct_choice_id": 205346,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59362,
      "choices": [
        {
          "id": 205349,
          "text": "Only Baby A (based on both criteria)"
        },
        {
          "id": 205350,
          "text": "Babies A and B (based on weight or gestational age)"
        },
        {
          "id": 205351,
          "text": "Babies A, B, and C (based on weight or gestational age)"
        },
        {
          "id": 205352,
          "text": "All babies (A, B, C, and D)"
        }
      ],
      "text": "A neonatal intensive care unit is updating its clinical practice guidelines for retinopathy of prematurity (ROP) screening. The quality improvement team identifies several recent admissions: Baby A (28 weeks, 1200g), Baby B (33 weeks, 1450g), Baby C (31 weeks, 1600g), and Baby D (35 weeks, 1900g). Each case has various complicating factors including prolonged oxygen therapy, sepsis, and blood transfusions. According to current American Academy of Pediatrics (AAP) recommendations, which infants require ROP screening?",
      "unique_key": "Q7647886",
      "question_audio": null,
      "question_video": null,
      "map_id": 34972695,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nBabies A, B, and C (based on weight or gestational age)\r\n\r\nExplanation: Current AAP guidelines recommend ROP screening for all infants with:\r\n\r\nBirth weight ≤1500g OR\r\n\r\nGestational age ≤32 weeks\r\n\r\nAdditionally, selected infants with birth weight between 1500-2000g or gestational age >32 weeks with an unstable clinical course should be screened if determined by the neonatologist to be at risk. Baby A meets both criteria, Baby B meets the gestational age criterion, and Baby C meets the gestational age criterion. Baby D doesn't meet either primary screening criterion.",
      "correct_choice_id": 205351,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59363,
      "choices": [
        {
          "id": 205353,
          "text": "Observation with weekly examinations and progression monitoring"
        },
        {
          "id": 205354,
          "text": "Immediate treatment with intravitreal anti-VEGF injection (bevacizumab)"
        },
        {
          "id": 205355,
          "text": "Laser photocoagulation to the avascular retina within 72 hours"
        },
        {
          "id": 205356,
          "text": "Surgical vitrectomy to prevent retinal detachment"
        }
      ],
      "text": "You're caring for a 12-week-old former 25-week premature infant (birth weight 650g) in follow-up. The ophthalmologist diagnoses Type 1 ROP in Zone II, Stage 3 with plus disease in both eyes during the weekly examination. The infant is currently on room air with stable respiratory status but has required multiple blood transfusions during the NICU stay. The parents are anxious about treatment options and potential outcomes. Which of the following represents the most appropriate initial management for this infant's ROP?",
      "unique_key": "Q9346790",
      "question_audio": null,
      "question_video": null,
      "map_id": 34300133,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Laser photocoagulation to the avascular retina within 72 hours Explanation: This infant has Type 1 ROP (Zone II, Stage 3 with plus disease), which meets treatment criteria based on ETROP study guidelines. Treatment should be administered within 72 hours of diagnosis. Laser photocoagulation remains the gold standard first-line treatment, involving ablation of the avascular peripheral retina to reduce VEGF production. While anti-VEGF therapy is an emerging alternative (especially for Zone I disease), laser therapy has longer follow-up data regarding safety and efficacy. Observation alone would be inappropriate for Type 1 ROP, and vitrectomy is reserved for advanced stages with retinal detachment.</p>\r\n",
      "correct_choice_id": 205355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59364,
      "choices": [
        {
          "id": 205357,
          "text": "CYP27B1 mutation affecting 1-alpha-hydroxylase"
        },
        {
          "id": 205358,
          "text": "PHEX gene mutation leading to elevated FGF23 levels"
        },
        {
          "id": 205359,
          "text": "CYP24A1 mutation causing vitamin D catabolism defect"
        },
        {
          "id": 205360,
          "text": "CLCN5 gene mutation affecting proximal tubular function"
        }
      ],
      "text": "You evaluate a 3-year-old boy referred by his pediatrician for progressive lower extremity bowing that has worsened despite adequate nutrition. His height is at the 3rd percentile. Physical examination reveals frontal bossing, widened wrists, significant genu varum (bowlegs), and waddling gait. Laboratory evaluation shows calcium 9.2 mg/dL (normal), phosphorus 2.1 mg/dL (low), alkaline phosphatase 620 U/L (elevated), 25-OH vitamin D 32 ng/mL (normal), 1,25-OH vitamin D 25 pg/mL (low-normal), and PTH 42 pg/mL (normal). Radiographs show fraying and cupping of metaphyses and widened growth plates. Which genetic mutation is most likely responsible for this patient's clinical presentation?",
      "unique_key": "Q4338095",
      "question_audio": null,
      "question_video": null,
      "map_id": 34848302,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) PHEX gene mutation leading to elevated FGF23 levels Explanation: This child demonstrates classic features of X-linked hypophosphatemic rickets (XLH), the most common form of heritable hypophosphatemic rickets. The hallmark laboratory finding is isolated hypophosphatemia with normal calcium, normal PTH, and inappropriately normal/low 1,25-OH vitamin D levels (relative to the hypophosphatemia). XLH results from inactivating mutations in the PHEX gene (phosphate-regulating endopeptidase homolog, X-linked), which leads to increased FGF23 activity. Elevated FGF23 causes phosphate wasting through inhibition of sodium-phosphate cotransporters in the proximal tubule and decreases 1,25-OH vitamin D production, resulting in hypophosphatemia resistant to conventional vitamin D therapy.</p>\r\n",
      "correct_choice_id": 205358,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59365,
      "choices": [
        {
          "id": 205361,
          "text": "Increasing oral phosphate dosing to achieve normal serum phosphorus"
        },
        {
          "id": 205362,
          "text": "Addition of growth hormone therapy to improve linear growth"
        },
        {
          "id": 205363,
          "text": "Initiating subcutaneous burosumab injections every 2-4 weeks"
        },
        {
          "id": 205364,
          "text": "Surgical correction of lower limb deformities followed by phosphate continuation"
        }
      ],
      "text": "A 5-year-old girl with genetically confirmed X-linked hypophosphatemic rickets has been treated with oral phosphate supplements and calcitriol for 3 years with partial improvement. However, she continues to have progressive lower limb deformities, bone pain that limits physical activity, and recurrent dental abscesses despite good compliance with medication. Her recent labs show serum phosphorus 2.4 mg/dL (low), ALP 498 U/L (elevated), FGF23 220 RU/mL (elevated), and TmP/GFR 1.9 mg/dL (low). Growth velocity is below the 25th percentile. Which therapy would be most appropriate to consider for this patient?",
      "unique_key": "Q1124737",
      "question_audio": null,
      "question_video": null,
      "map_id": 34409782,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Initiating subcutaneous burosumab injections every 2-4 weeks Explanation: This patient has suboptimal response to conventional therapy for XLH (phosphate supplements and calcitriol) with persistent hypophosphatemia, elevated FGF23, and progressive clinical manifestations including bone deformities, dental issues, and poor growth. Burosumab is an FDA-approved monoclonal antibody that targets FGF23, blocking its phosphaturic effect. Administered as subcutaneous injections every 2-4 weeks, burosumab has shown superior efficacy compared to conventional therapy in improving serum phosphorus, radiographic healing of rickets, physical function, and growth velocity. Increasing oral phosphate risks secondary hyperparathyroidism and nephrocalcinosis, while surgical correction without addressing the underlying metabolic derangement leads to recurrence.</p>\r\n",
      "correct_choice_id": 205363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59366,
      "choices": [
        {
          "id": 205365,
          "text": "Nutritional vitamin D deficiency"
        },
        {
          "id": 205366,
          "text": "Vitamin D-dependent rickets type 1 (CYP27B1 deficiency)"
        },
        {
          "id": 205367,
          "text": "Vitamin D-dependent rickets type 2 (vitamin D receptor defect)"
        },
        {
          "id": 205368,
          "text": "Hypophosphatemic rickets due to FGF23 excess"
        }
      ],
      "text": "You evaluate a 16-month-old girl with failure to thrive, developmental delay, and muscle weakness. Physical examination reveals frontal bossing, rachitic rosary, Harrison's groove, and wrist widening. Laboratory studies show hypocalcemia (7.2 mg/dL), hypophosphatemia (2.8 mg/dL), markedly elevated PTH (320 pg/mL), and alkaline phosphatase (980 U/L). Surprisingly, the 1,25-OH vitamin D level is markedly elevated at 220 pg/mL (normal 20-79). The child was previously treated with standard doses of cholecalciferol with minimal improvement. Family history reveals consanguinity (parents are first cousins). Which of the following is the most likely diagnosis in this patient?",
      "unique_key": "Q8411211",
      "question_audio": null,
      "question_video": null,
      "map_id": 34708806,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Vitamin D-dependent rickets type 2 (vitamin D receptor defect) Explanation: This case presents classic features of vitamin D-dependent rickets type 2 (VDDR-2), characterized by end-organ resistance to 1,25-dihydroxyvitamin D action due to mutations in the vitamin D receptor (VDR) gene. The hallmark laboratory finding is markedly elevated 1,25-OH vitamin D levels with hypocalcemia, hypophosphatemia, and secondary hyperparathyroidism&mdash;indicating that the body is producing adequate active vitamin D, but target tissues cannot respond appropriately. The consanguinity suggests an autosomal recessive inheritance pattern consistent with VDDR-2. Treatment is challenging and requires supraphysiological doses of calcium (often intravenously initially) and calcitriol. Some patients with partial VDR defects may respond to extremely high doses of calcitriol, while those with complete receptor defects may require long-term intravenous calcium infusions or calcium-enriched hyperalimentation solutions.</p>\r\n",
      "correct_choice_id": 205367,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59367,
      "choices": [
        {
          "id": 205369,
          "text": "Autosomal dominant; 50% risk for each child regardless of sex"
        },
        {
          "id": 205370,
          "text": "X-linked recessive; 50% risk for male offspring, female offspring will be carriers"
        },
        {
          "id": 205371,
          "text": "X-linked recessive; 25% risk for sons only, daughters unaffected"
        },
        {
          "id": 205372,
          "text": "Autosomal recessive; 25% risk for each child regardless of sex"
        }
      ],
      "text": "A 6-year-old boy is brought to the pediatric hematology clinic for evaluation of recurrent episodes of hemolysis following consumption of fava beans. His mother reports that her maternal uncle and brother experienced similar symptoms throughout their lives. Physical examination is unremarkable. CBC shows hemoglobin of 10.2 g/dL with reticulocytosis. Laboratory studies reveal decreased G6PD enzyme activity. The patient's parents appear asymptomatic, and his 8-year-old sister has never experienced similar symptoms despite eating the same foods. The family is planning another pregnancy and requests genetic counseling. Which statement best characterizes the inheritance pattern and recurrence risk for this condition?",
      "unique_key": "Q5331527",
      "question_audio": null,
      "question_video": null,
      "map_id": 34010006,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) X-linked recessive; 50% risk for male offspring, female offspring will be carriers Explanation: This case describes G6PD deficiency, a classic X-linked recessive disorder. Key features include: (1) predominantly male affected individuals, (2) transmission through asymptomatic carrier females, (3) no male-to-male transmission, and (4) skipping generations through female carriers. The mother is an obligate carrier, with her uncle and brother (maternal relatives) also affected. For each pregnancy, there is a 50% chance of passing the mutated X chromosome to any child. Sons who inherit it will express the disease (having only one X chromosome), while daughters will be asymptomatic carriers (having a normal X from their father). In rare cases, female carriers may show mild symptoms due to unfavorable X-inactivation patterns, but full expression in females is uncommon in X-linked recessive conditions.</p>\r\n",
      "correct_choice_id": 205370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59368,
      "choices": [
        {
          "id": 205373,
          "text": "Gene therapy using CRISPR-Cas9 to correct the MECP2 mutation"
        },
        {
          "id": 205374,
          "text": "IGF-1 (mecasermin) or trofinetide to improve synaptic function"
        },
        {
          "id": 205375,
          "text": "High-dose folinic acid to overcome cerebral folate deficiency"
        },
        {
          "id": 205376,
          "text": "Deep brain stimulation targeting the subthalamic nucleus"
        }
      ],
      "text": "You evaluate a 30-month-old girl with developmental regression. After normal development until 14 months, she lost purposeful hand movements, developed stereotypic hand-wringing, and experienced language regression. Parents report declining interest in social interaction, irritability, and disrupted sleep patterns. Head circumference growth has plateaued since 12 months. EEG shows abnormal patterns with epileptiform discharges. Genetic testing reveals a de novo mutation in the MECP2 gene. Parents are distraught about prognosis and ask about therapeutic options for their daughter's breathing abnormalities, seizures, and sleep disturbances. Which therapeutic approach has shown the most evidence for ameliorating symptoms in this condition?",
      "unique_key": "Q6231347",
      "question_audio": null,
      "question_video": null,
      "map_id": 34817569,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) IGF-1 (mecasermin) or trofinetide to improve synaptic function Explanation: This child has classic Rett syndrome, an X-linked dominant neurodevelopmental disorder caused by mutations in MECP2 (methyl-CpG-binding protein 2). The condition is characterized by normal early development followed by regression of language and motor skills, stereotypic hand movements, microcephaly, seizures, breathing irregularities, and sleep disturbances. While treatment remains largely symptomatic (antiepileptics for seizures, melatonin for sleep, etc.), IGF-1 and its derivative trofinetide have shown promising results in clinical trials. These agents have been found to partially rescue synaptic defects in Rett syndrome by enhancing synaptic maturation and function. Trofinetide (NNZ-2566) was granted FDA approval in March 2023 for Rett syndrome, making it the first approved therapy specifically targeting underlying pathophysiology rather than just symptoms. Gene therapy approaches remain experimental, and GABA modulation has not shown consistent benefits.</p>\r\n",
      "correct_choice_id": 205374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59369,
      "choices": [
        {
          "id": 205377,
          "text": "Aspirin (80-100mg/kg/day) alone for 14 days, then low-dose aspirin for 6-8 weeks"
        },
        {
          "id": 205378,
          "text": "IVIG 2g/kg as a single infusion plus high-dose aspirin, followed by low-dose aspirin until 6-8 weeks"
        },
        {
          "id": 205379,
          "text": "Pulse methylprednisolone (30mg/kg/day) for 3 days followed by oral prednisolone taper"
        },
        {
          "id": 205380,
          "text": "Infliximab (5mg/kg) as a single dose plus low-dose aspirin for 6-8 weeks"
        }
      ],
      "text": "A previously healthy 3-year-old boy presents with 6 days of high fever (39.5°C) unresponsive to antipyretics. Physical examination reveals bilateral conjunctival injection without exudate, erythematous cracked lips, strawberry tongue, diffuse maculopapular rash, cervical lymphadenopathy (3.5cm, unilateral), and marked erythema and edema of hands and feet. Laboratory studies show elevated ESR (68mm/hr), CRP (12.5mg/dL), WBC (18,500/μL with left shift), platelets (450,000/μL), and mild transaminitis. Echocardiogram shows bright coronary arteries without dilation. The child is irritable and refuses oral intake. Which therapeutic approach would provide the greatest reduction in risk of coronary artery aneurysms?",
      "unique_key": "Q9731564",
      "question_audio": null,
      "question_video": null,
      "map_id": 34054704,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) IVIG 2g/kg as a single infusion plus high-dose aspirin, followed by low-dose aspirin until 6-8 weeks Explanation: This child presents with classic Kawasaki disease (KD), meeting all diagnostic criteria: fever &ge;5 days plus 4 of 5 principal clinical features (conjunctival injection, oral mucosal changes, peripheral extremity changes, polymorphous rash, cervical lymphadenopathy). The primary goal of treatment is preventing coronary artery aneurysms, which occur in 20-25% of untreated patients but &lt;5% with timely appropriate therapy. IVIG (2g/kg) as a single infusion within 10 days of fever onset plus aspirin is the gold standard first-line therapy, reducing inflammation and thrombotic risk. High-dose aspirin (80-100mg/kg/day divided QID) is used during the acute phase until the patient is afebrile, followed by low-dose aspirin (3-5mg/kg/day) until 6-8 weeks when coronary arteries are confirmed normal. While corticosteroids may be beneficial in high-risk patients or as rescue therapy, they are not recommended as routine initial treatment over IVIG monotherapy.</p>\r\n",
      "correct_choice_id": 205378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59370,
      "choices": [
        {
          "id": 205381,
          "text": "Continue antibiotics and observe for development of additional clinical criteria"
        },
        {
          "id": 205382,
          "text": "Perform echocardiography and initiate IVIG if coronary abnormalities are present"
        },
        {
          "id": 205383,
          "text": "Initiate IVIG 2g/kg and aspirin therapy based on current clinical and laboratory findings"
        },
        {
          "id": 205384,
          "text": "Perform lumbar puncture to rule out meningitis before considering KD therapy"
        }
      ],
      "text": "You evaluate a 14-month-old girl with 5 days of persistent fever (40°C) despite appropriate antibiotics for presumed otitis media. She appears irritable with bilateral non-purulent conjunctival injection and a faint truncal rash that appeared yesterday. Her palms and soles show minimal erythema. She has no significant lymphadenopathy, and her lips appear only slightly erythematous. Laboratory evaluation reveals: WBC 17,200/μL, Hgb 10.1g/dL, platelets 480,000/μL, CRP 8.2mg/dL, ESR 62mm/hr, ALT 120 U/L, albumin 2.8g/dL, and sterile pyuria on urinalysis. The parents report that the child has been unusually fussy and refusing to walk. Based on American Heart Association guidelines, what is the most appropriate next step in management?",
      "unique_key": "Q3863522",
      "question_audio": null,
      "question_video": null,
      "map_id": 34795163,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Initiate IVIG 2g/kg and aspirin therapy based on current clinical and laboratory findings Explanation: This child presents with incomplete (atypical) Kawasaki disease, having persistent fever but only 2-3 of the principal clinical features. The 2017 AHA guidelines recommend that incomplete KD be considered in any infant or child with unexplained fever for &ge;5 days with 2-3 clinical criteria plus elevated inflammatory markers. This patient has supporting laboratory findings that meet the threshold for treatment: CRP &ge;3mg/dL, ESR &ge;40mm/hr, plus 3 supplemental laboratory criteria (albumin &le;3g/dL, elevated ALT, platelets &ge;450,000/&mu;L after 7 days, and WBC &ge;15,000/&mu;L). Importantly, incomplete KD carries the same risk of coronary artery abnormalities as complete KD. Delaying therapy while awaiting additional clinical criteria could increase coronary complication risk. Prompt treatment with IVIG and aspirin is indicated, even without performing echocardiography first, though baseline echocardiography should be obtained as soon as feasible.</p>\r\n",
      "correct_choice_id": 205383,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59371,
      "choices": [
        {
          "id": 205385,
          "text": "Supportive care only with IV fluids and pain management"
        },
        {
          "id": 205386,
          "text": "Oral prednisolone 1-2mg/kg/day for 1-2 weeks"
        },
        {
          "id": 205387,
          "text": "Single high-dose IV methylprednisolone pulse (30mg/kg)"
        },
        {
          "id": 205388,
          "text": "IVIG 2g/kg as a single infusion"
        },
        {
          "id": 205389,
          "text": "Cyclophosphamide plus high-dose corticosteroids"
        }
      ],
      "text": "A previously healthy 8-year-old boy presents to the emergency department with severe, colicky abdominal pain, hematemesis, and palpable purpuric rash on his lower extremities and buttocks that appeared 3 days after an upper respiratory tract infection. He reports arthralgia in both ankles and complains of testicular pain. Abdominal CT shows segmental bowel wall thickening with surrounding mesenteric edema in the jejunum and terminal ileum. Urinalysis shows microscopic hematuria but normal creatinine. Surgical consultation ruled out intussusception, but the patient remains in significant pain despite opioid analgesia. Which of the following is the most appropriate treatment approach for this patient's gastrointestinal manifestations?",
      "unique_key": "Q5579082",
      "question_audio": null,
      "question_video": null,
      "map_id": 34572678,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nOral prednisolone 1-2mg/kg/day for 1-2 weeks\r\n\r\nExplanation: This patient presents with Henoch-Schönlein purpura (HSP)/IgA vasculitis with significant gastrointestinal involvement manifesting as severe abdominal pain, hematemesis, and radiographic evidence of vasculitis-induced bowel wall inflammation. While HSP is typically self-limiting with supportive care only, corticosteroid therapy is indicated for severe gastrointestinal symptoms, particularly when associated with significant pain, bleeding, or risk of complications like intussusception. Numerous studies support short-course oral prednisolone (1-2mg/kg/day for 1-2 weeks) for moderately severe GI manifestations, demonstrating faster resolution of abdominal pain and reduced risk of intussusception or surgical intervention. High-dose pulse steroids are generally reserved for severe renal involvement rather than GI manifestations. IVIG has limited evidence in HSP, and cytotoxic agents like cyclophosphamide would be excessive for isolated GI involvement without severe nephritis.",
      "correct_choice_id": 205386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59372,
      "choices": [
        {
          "id": 205390,
          "text": "Oral prednisolone 1mg/kg/day for 4-6 weeks"
        },
        {
          "id": 205391,
          "text": "Pulse methylprednisolone followed by oral prednisolone alone"
        },
        {
          "id": 205392,
          "text": "Cyclophosphamide plus pulse methylprednisolone followed by oral prednisolone"
        },
        {
          "id": 205393,
          "text": "Mycophenolate mofetil plus low-dose prednisolone"
        }
      ],
      "text": "A 14-year-old girl is brought to the emergency department with periorbital edema, hypertension (BP 158/96 mmHg), and gross hematuria. Three weeks prior, she developed palpable purpuric rash on her lower extremities and buttocks with mild abdominal pain and arthralgia, diagnosed as HSP and managed supportively. Laboratory studies now show: BUN 54 mg/dL, creatinine 2.8 mg/dL (baseline 0.7 mg/dL two weeks ago), albumin 2.4 g/dL, and urinalysis with >100 RBC/hpf, RBC casts, and 3+ protein. Urine protein-to-creatinine ratio is 3.8 g/g. Complement levels are normal. Renal biopsy reveals diffuse mesangial and endocapillary proliferation with crescents in 60% of glomeruli and predominant mesangial IgA deposits. Which therapeutic approach is most appropriate for this patient's renal disease?",
      "unique_key": "Q5618212",
      "question_audio": null,
      "question_video": null,
      "map_id": 34557797,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Cyclophosphamide plus pulse methylprednisolone followed by oral prednisolone Explanation: This patient presents with rapidly progressive glomerulonephritis (RPGN) as a complication of HSP/IgA vasculitis, evidenced by acute kidney injury, active urinary sediment, and biopsy findings of crescentic nephritis with IgA deposits. The presence of crescents in &gt;50% of glomeruli indicates severe disease with high risk of progression to end-stage renal disease. For HSP nephritis presenting as RPGN with extensive crescents, aggressive immunosuppression with combined cyclophosphamide and corticosteroids is recommended based on extrapolation from other forms of crescentic GN and small observational studies in severe HSP nephritis. The typical regimen includes intravenous cyclophosphamide (monthly pulses of 500-1000 mg/m&sup2;) for 6 months plus methylprednisolone pulses (15-30 mg/kg/day for 3 days) followed by oral prednisolone. This approach has shown superior outcomes compared to steroids alone or supportive care in preventing progression to ESRD in severe crescentic HSP nephritis. Less aggressive therapies would be insufficient given the severity and rapid progression of this patient&#39;s renal disease.</p>\r\n",
      "correct_choice_id": 205392,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59373,
      "choices": [
        {
          "id": 205394,
          "text": "Administer dexamethasone"
        },
        {
          "id": 205395,
          "text": "Continue supportive care"
        },
        {
          "id": 205396,
          "text": "Prescribe azithromycin"
        },
        {
          "id": 205397,
          "text": "Refer for laryngoscopy"
        }
      ],
      "text": "A previously healthy 2-year-old boy is seen in the office for a worsening cough. The illness started 2 days ago with cough, rhinorrhea, and a fever of 38.3°C. His mother describes the cough as having a harsh, seal-like quality. The boy’s temperature is 38°C, heart rate is 110 beats/min, respiratory rate is 25 breaths/min, oxygen saturation is 99% on room air, and blood pressure is 90/60 mm Hg. At rest, he has a frequent seal-like cough; he is not in respiratory distress and has no stridor. His lungs are clear to auscultation bilaterally with good aeration, and he has no chest wall retractions. When he becomes more active, the boy has mild stridor and mild retractions. Of the following, the BEST next step in management of the boy’s symptoms is to",
      "unique_key": "Q3361019",
      "question_audio": null,
      "question_video": null,
      "map_id": 34803005,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A)  \r\n\r\nThe boy in the vignette has signs and symptoms consistent with a diagnosis of croup (laryngotracheitis). Because he has signs of worsening upper airway inflammation and obstruction, administering dexamethasone is the best next step to manage his symptoms. Continuing supportive care is inadequate because of his worsening symptoms. Treatment with azithromycin is inappropriate because he has no signs of bacterial infection. Laryngoscopy is also not indicated at this time because he does not have recurrent, prolonged, or severe disease.",
      "correct_choice_id": 205394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59374,
      "choices": [
        {
          "id": 205398,
          "text": "Hypernatremic dehydration is the most likely cause of his symptoms due to excessive salt loss in sweat"
        },
        {
          "id": 205399,
          "text": "Distal intestinal obstruction syndrome is a common complication in adolescents with CF and may be precipitated by respiratory infections"
        },
        {
          "id": 205400,
          "text": "Rectal prolapse should be immediately suspected and evaluated, as it remains a common complication in modern CF care"
        },
        {
          "id": 205401,
          "text": "Intestinal lymphangiectasia with protein-losing enteropathy is the likely underlying cause of his abdominal symptoms"
        }
      ],
      "text": "A 14-year-old boy with cystic fibrosis (F508del homozygous) presents to the emergency department with a 2-day history of progressive right lower quadrant pain, abdominal distension, and decreased stool frequency despite taking his pancreatic enzyme replacement therapy. He has been experiencing increasing cough with thick sputum production over the past week and his mother reports he's been less compliant with his airway clearance techniques. Physical examination reveals a distended, tender abdomen with a palpable mass in the right lower quadrant. His last admission was 3 months ago for a pulmonary exacerbation. Which of the following statements is most accurate regarding this patient's condition?",
      "unique_key": "Q4043461",
      "question_audio": null,
      "question_video": null,
      "map_id": 34677711,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Distal intestinal obstruction syndrome is a common complication in adolescents with CF and may be precipitated by respiratory infections Explanation: This patient presents with classic symptoms of distal intestinal obstruction syndrome (DIOS), previously called meconium ileus equivalent, which occurs in approximately 10-20% of adolescents and adults with CF. DIOS is characterized by complete or incomplete intestinal obstruction caused by abnormally viscid mucofeculent material in the terminal ileum and proximal colon. Risk factors include severe CFTR mutations (like F508del), history of meconium ileus, poor adherence to pancreatic enzyme therapy, dehydration, and concurrent pulmonary exacerbations. This patient&#39;s presentation with RLQ pain, distension, and a palpable fecal mass during a pulmonary exacerbation is highly consistent with DIOS. While rectal prolapse can occur in CF, modern enzyme replacement therapy has made it much less common. Hypernatremia (rather than hyponatremia) is uncommon in CF even with significant sweating, and intestinal lymphangiectasia is not a typical CF manifestation.</p>\r\n",
      "correct_choice_id": 205399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59375,
      "choices": [
        {
          "id": 205402,
          "text": "Bronchoscopy with bronchoalveolar lavage for microbiological culture"
        },
        {
          "id": 205403,
          "text": "Sweat chloride testing regardless of newborn screening results, followed by CFTR genetic analysis if elevated"
        },
        {
          "id": 205404,
          "text": "Fecal pancreatic elastase measurement alone"
        },
        {
          "id": 205405,
          "text": "High-resolution chest CT to evaluate for bronchiectasis"
        }
      ],
      "text": "A 9-month-old girl presents with failure to thrive despite adequate caloric intake, recurrent wheezing episodes requiring multiple courses of antibiotics, and chronic loose, foul-smelling stools. She was born at term with no complications and passed her newborn screening, which you confirm included cystic fibrosis screening. Family history reveals a paternal aunt with \"lung problems\" who died in early adulthood. On examination, the infant's weight is below the 3rd percentile while her length is at the 25th percentile. She has mild digital clubbing and scattered crackles on lung auscultation. Recent chest radiographs show hyperinflation and peribronchial thickening. Which diagnostic approach would be most appropriate to confirm the suspected diagnosis?",
      "unique_key": "Q2056042",
      "question_audio": null,
      "question_video": null,
      "map_id": 34097734,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B) Sweat chloride testing regardless of newborn screening results, followed by CFTR genetic analysis if elevated Explanation: Despite a reportedly normal newborn screening, this infant presents with classic multisystem manifestations of cystic fibrosis (CF): failure to thrive, recurrent respiratory infections, and steatorrhea suggesting pancreatic insufficiency. Newborn screening has a sensitivity of 95-98%, meaning 2-5% of CF cases may be missed. False-negative results can occur with certain mutations, specimen collection errors, or testing limitations. The gold standard for diagnosis remains the sweat chloride test regardless of newborn screening results, with values &gt;60 mmol/L being diagnostic in the appropriate clinical context. Two positive sweat tests should be followed by CFTR genetic analysis to confirm the diagnosis and determine the specific mutation(s), which has implications for prognosis and eligibility for CFTR modulator therapies. Fecal elastase may confirm pancreatic insufficiency but is not specific for CF. Bronchoscopy and CT can help characterize lung disease but are not first-line diagnostic tools. A therapeutic trial is inappropriate without confirming the diagnosis.</p>\r\n",
      "correct_choice_id": 205403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59376,
      "choices": [
        {
          "id": 205406,
          "text": "Addition of inhaled tobramycin on alternate months for Pseudomonas eradication and maintenance"
        },
        {
          "id": 205407,
          "text": "Initiation of ivacaftor monotherapy targeting his G551D mutation"
        },
        {
          "id": 205408,
          "text": "Combination therapy with elexacaftor/tezacaftor/ivacaftor (Trikafta®)"
        },
        {
          "id": 205409,
          "text": "Inhaled aztreonam lysine added to current regimen"
        }
      ],
      "text": "A 10-year-old boy with cystic fibrosis (genotype F508del/G551D) has been managed with standard therapies including pancreatic enzyme replacement, airway clearance techniques, inhaled dornase alfa, and hypertonic saline. Despite good adherence, he has experienced three pulmonary exacerbations requiring IV antibiotics in the past year. His current FEV₁ is 72% predicted, decreased from 85% one year ago. His BMI is at the 35th percentile for age. Respiratory culture grows Pseudomonas aeruginosa (first time) and methicillin-sensitive Staphylococcus aureus. At this clinic visit, his parents inquire about newer treatment options that might help stabilize his lung function. Which treatment approach would most likely provide significant improvement in this patient's lung function and reduce exacerbation frequency?",
      "unique_key": "Q1743969",
      "question_audio": null,
      "question_video": null,
      "map_id": 34983070,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C) Combination therapy with elexacaftor/tezacaftor/ivacaftor (Trikafta&reg;) Explanation: This patient would benefit most from elexacaftor/tezacaftor/ivacaftor (Trikafta&reg;), a triple-combination CFTR modulator therapy approved in 2019 for patients &ge;6 years with at least one F508del mutation or another responsive mutation. This patient&#39;s genotype (F508del/G551D) makes him an excellent candidate. Clinical trials demonstrated remarkable improvements with this therapy, including average FEV₁ increases of 10-14 percentage points, 63% reduction in pulmonary exacerbations, improved BMI, and decreased sweat chloride levels. While ivacaftor monotherapy would be effective for his G551D mutation, the triple combination provides superior efficacy for patients with F508del, targeting multiple defects in CFTR protein processing and function. Inhaled antibiotics (tobramycin or aztreonam) would be appropriate for Pseudomonas management but would not address the underlying CFTR dysfunction. Azithromycin has anti-inflammatory properties and modest benefits in CF but lacks the transformative impact of CFTR modulators. The introduction of highly effective modulator therapy has dramatically changed the CF treatment landscape, with patients experiencing unprecedented improvements in lung function, nutritional status, and quality of life.RetryClaude can make mistakes. Please double-check responses.</p>\r\n",
      "correct_choice_id": 205408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59377,
      "choices": [
        {
          "id": 205410,
          "text": "Sodium 124 mEq/L, potassium 6.5 mEq/L, chloride 86 mEq/L, glucose 42 mg/dL, bicarbonate 16 mEq/L"
        },
        {
          "id": 205411,
          "text": "Sodium 132 mEq/L, potassium 5.1 mEq/L, chloride 92 mEq/L, glucose 52 mg/dL, bicarbonate 18 mEq/L"
        },
        {
          "id": 205412,
          "text": "Sodium 125 mEq/L, potassium 3.2 mEq/L, chloride 87 mEq/L, glucose 62 mg/dL, bicarbonate 28 mEq/L"
        },
        {
          "id": 205413,
          "text": "Sodium 145 mEq/L, potassium 3.5 mEq/L, chloride 105 mEq/L, glucose 38 mg/dL, bicarbonate 20 mEq/L"
        }
      ],
      "text": "A 12-day-old male neonate is brought to the emergency department with a 24-hour history of poor feeding, vomiting, and progressive lethargy. He was born at term after an uncomplicated pregnancy and was discharged home on day 2 of life with normal newborn screening results from the state that does not include CAH. Parents report decreased wet diapers over the past day. Physical examination reveals temperature 36.8°C, heart rate 188/min, respiratory rate 65/min, blood pressure 50/30 mmHg, markedly decreased skin turgor, sunken fontanelle, capillary refill time of 5 seconds, and mild hyperpigmentation of the scrotum. He appears critically ill. Which set of laboratory findings would be most consistent with the suspected diagnosis?",
      "unique_key": "Q9991345",
      "question_audio": null,
      "question_video": null,
      "map_id": 34737885,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (A) Sodium 124 mEq/L, potassium 6.5 mEq/L, chloride 86 mEq/L, glucose 42 mg/dL, bicarbonate 16 mEq/L Explanation: This neonate presents with classic features of salt-wasting congenital adrenal hyperplasia (SW-CAH) due to 21-hydroxylase deficiency. The typical presentation occurs in the second week of life (7-14 days) when the infant develops signs of acute adrenal insufficiency: dehydration, hypotension, shock, hyponatremia, hyperkalemia, and metabolic acidosis. The pathophysiology involves deficient cortisol and aldosterone production with excessive androgen synthesis. Aldosterone deficiency leads to renal sodium wasting and potassium retention, resulting in hyponatremia and hyperkalemia. Cortisol deficiency contributes to hypoglycemia, poor cardiac function, hypotension, and decreased stress response. The mild hyperpigmentation results from elevated ACTH levels cross-stimulating melanocyte-stimulating hormone receptors. The laboratory pattern in option A (severe hyponatremia, hyperkalemia, hypochloremia, hypoglycemia, and metabolic acidosis) is pathognomonic for salt-wasting CAH in a neonate presenting with circulatory collapse. This represents a medical emergency requiring immediate fluid resuscitation, stress-dose hydrocortisone, and fludrocortisone.</p>\r\n",
      "correct_choice_id": 205410,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59378,
      "choices": [
        {
          "id": 205414,
          "text": "Obtain urgent karyotype analysis and pelvic ultrasound before initiating therapy"
        },
        {
          "id": 205415,
          "text": "IV normal saline bolus 20 mL/kg, then maintenance fluids with oral hydrocortisone 20 mg/m2/day"
        },
        {
          "id": 205416,
          "text": "IV hydrocortisone 50-100 mg/m2 bolus, followed by 50-100 mg/m²/day continuous infusion, plus normal saline resuscitation with dextrose supplementation"
        },
        {
          "id": 205417,
          "text": "Emergent endocrine consultation and bilateral gonadal biopsy to establish genetic sex before treatment"
        }
      ],
      "text": "A 9-day-old newborn is brought to the emergency department with progressive lethargy, poor feeding, and vomiting for the past 24 hours. The baby was discharged from the nursery on day 3 of life after an uncomplicated term delivery. The parents report significantly decreased wet diapers over the past day. On examination, the infant appears critically ill with temperature 36.5°C, heart rate 175/min, respiratory rate 60/min, blood pressure 55/32 mmHg, and delayed capillary refill of 4 seconds. You note ambiguous genitalia with clitoromegaly/micropenis, incomplete labioscrotal fusion, and hyperpigmentation. Laboratory studies reveal Na+ 122 mEq/L, K+ 7.1 mEq/L, glucose 38 mg/dL, pH 7.22, and HCO3- 14 mEq/L. Which of the following represents the most appropriate initial management for this neonate?",
      "unique_key": "Q5805613",
      "question_audio": null,
      "question_video": null,
      "map_id": 34812013,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nIV hydrocortisone 50-100 mg/m² bolus, followed by 50-100 mg/m²/day continuous infusion, plus normal saline resuscitation with dextrose supplementation\r\n\r\nExplanation: This neonate presents with classic salt-wasting congenital adrenal hyperplasia (SW-CAH) due to 21-hydroxylase deficiency in adrenal crisis. The combination of ambiguous genitalia (virilization in genetic females due to excess androgens), hyperpigmentation (from elevated ACTH), and life-threatening adrenal crisis developing in the second week of life (hyponatremia, hyperkalemia, hypoglycemia, shock) creates a medical emergency that requires immediate intervention.\r\nManagement priorities:\r\n\r\nTreat the adrenal crisis immediately—diagnostic confirmation can occur simultaneously but should not delay treatment. IV hydrocortisone at stress doses provides both glucocorticoid and mineralocorticoid activity, addressing both cortisol deficiency and aldosterone deficiency.\r\nAggressive fluid resuscitation with normal saline (10-20 mL/kg boluses, repeated as needed) to restore intravascular volume and correct hypotension.\r\n\r\nGlucose supplementation (D10W) to correct hypoglycemia.\r\n\r\nSpecific hyperkalemia treatment if ECG changes present (cardiac monitoring essential).\r\nOnce stabilized, additional laboratory studies should be obtained (17-OHP, ACTH, plasma renin activity, androstenedione, testosterone) and genetic studies (karyotype, CFTR genotyping).\r\n\r\nWhile gender assignment is important, the life-threatening metabolic derangements take priority over definitive diagnosis of genetic sex (options A and D). Oral medications (option B) are inappropriate in shock, and dexamethasone (option E) lacks mineralocorticoid activity needed to address salt wasting. After stabilization, long-term management will include hydrocortisone, fludrocortisone, and salt supplementation, with multidisciplinary involvement of endocrinology, genetics, urology, psychology, and ethics for gender assignment and potential surgical management.",
      "correct_choice_id": 205416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59379,
      "choices": [
        {
          "id": 205418,
          "text": "Weight-for-height/length < -3 SD or MUAC < 115 mm or bilateral pitting edema"
        },
        {
          "id": 205419,
          "text": "Weight-for-age < -3 SD or height-for-age < -3 SD"
        },
        {
          "id": 205420,
          "text": "Weight-for-height/length < -2 SD to < -3 SD with no edema"
        },
        {
          "id": 205421,
          "text": "BMI-for-age < -2 SD with no complications"
        }
      ],
      "text": "A community health worker is screening children under 5 years of age in a rural area with high prevalence of malnutrition. During the assessment, the worker needs to identify cases of severe acute malnutrition (SAM) requiring referral to the nutritional rehabilitation center. According to the WHO guidelines, which of the following parameters correctly defines SAM in children 6-59 months of age?",
      "unique_key": "Q2327740",
      "question_audio": null,
      "question_video": null,
      "map_id": 34545288,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A)  \r\n\r\nWeight-for-height/length < -3 SD or MUAC < 115 mm or bilateral pitting edema\r\n\r\nExplanation: According to WHO guidelines, severe acute malnutrition (SAM) in children 6-59 months is defined by any one of these three criteria: 1) Weight-for-height/length less than -3 standard deviations (z-scores) below the median of WHO growth standards, 2) Mid-Upper Arm Circumference (MUAC) less than 115 mm, or 3) Presence of bilateral pitting edema regardless of anthropometric measurements. Weight-for-age < -3 SD indicates severe underweight but doesn't specifically diagnose SAM. Height-for-age < -3 SD indicates stunting (chronic malnutrition). Weight-for-height/length between -2 SD and -3 SD without edema defines moderate acute malnutrition (MAM), not SAM. It's critical to distinguish between SAM and MAM as management approaches differ significantly, with SAM requiring more intensive medical and nutritional therapy.",
      "correct_choice_id": 205418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59380,
      "choices": [
        {
          "id": 205422,
          "text": "No weight gain after completing 5 days in transition phase despite adequate feeding"
        },
        {
          "id": 205423,
          "text": "Development of diarrhea during any phase of treatment"
        },
        {
          "id": 205424,
          "text": "Persistence of bilateral pitting edema after 5 days of treatment"
        },
        {
          "id": 205425,
          "text": "Failure to achieve 10 g/kg/day weight gain during first week of rehabilitation phase"
        }
      ],
      "text": "A 16-month-old girl with severe acute malnutrition has been receiving treatment according to WHO protocols for 21 days. She was admitted with weight-for-length z-score of -4.0 SD, MUAC of 102 mm, and bilateral pitting edema (+2). Despite following the recommended nutritional rehabilitation protocol, her clinical condition has not improved as expected. The treatment team is concerned about failure to respond to standard therapy. Which of the following findings would indicate failure to respond to treatment in this child with SAM?",
      "unique_key": "Q3096182",
      "question_audio": null,
      "question_video": null,
      "map_id": 34995534,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A)  \r\n\r\nNo weight gain after completing 5 days in transition phase despite adequate feeding\r\n\r\nExplanation: The WHO defines several criteria for failure to respond in SAM treatment, with specific timelines for different clinical parameters. Key indicators include: 1) Failure to regain appetite by day 4, 2) Failure to start losing edema by day 4, 3) Presence of edema on day 10, 4) Failure to gain at least 5g/kg/day weight for 3 consecutive days after transition phase when receiving 175-200 kcal/kg/day, 5) No weight gain after 5 days in transition phase. The transition phase typically occurs after stabilization and before the rehabilitation phase, during which nutritional intake is gradually increased. Option A correctly identifies a criterion for failure to respond. Option B is incorrect because transient diarrhea may occur during treatment and isn't automatically considered treatment failure. Option C is too stringent—edema should start reducing by day 4, but complete resolution isn't expected that quickly. Option D is incorrect—expected weight gain during rehabilitation is 5-10 g/kg/day, not a minimum of 10g. Option E is not a standard criterion for treatment failure; anemia often improves gradually during nutritional rehabilitation.",
      "correct_choice_id": 205422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59381,
      "choices": [
        {
          "id": 205426,
          "text": "Severe acute malnutrition requiring immediate referral to inpatient treatment"
        },
        {
          "id": 205427,
          "text": "Moderate acute malnutrition eligible for supplementary feeding program"
        },
        {
          "id": 205428,
          "text": "Moderate stunting with normal weight-for-height"
        },
        {
          "id": 205429,
          "text": "Severe underweight but not acutely malnourished"
        }
      ],
      "text": "A primary care physician is conducting nutritional screening in a community clinic. A 20-month-old boy is brought in by his mother with concerns about inadequate weight gain. The child appears thin but alert and active. Anthropometric measurements reveal: Weight: 8.4 kg Length: 78 cm MUAC: 122 mm No edema detected on examination Weight-for-age z-score: -2.8 SD Height-for-age z-score: -1.6 SD Weight-for-height z-score: -2.4 SD The child has good appetite and no acute illness. His immunizations are up to date, and developmental milestones are appropriate for age. Based on these anthropometric and clinical findings, what is the correct nutritional diagnosis for this child?",
      "unique_key": "Q4994653",
      "question_audio": null,
      "question_video": null,
      "map_id": 34598006,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nModerate acute malnutrition eligible for supplementary feeding program\r\n\r\nExplanation: This child has moderate acute malnutrition (MAM) based on his weight-for-height z-score of -2.4 SD, which falls between -2 SD and -3 SD below the WHO median reference. This finding, combined with MUAC of 122 mm (between 115-125 mm), confirms moderate acute malnutrition. The absence of bilateral pitting edema and the fact that measurements don't cross the severe thresholds (WFH < -3 SD or MUAC < 115 mm) rule out severe acute malnutrition (SAM). The child's weight-for-age z-score of -2.8 SD indicates severe underweight, but nutritional status classification prioritizes weight-for-height/MUAC assessment for determining acute malnutrition. His height-for-age z-score of -1.6 SD indicates mild stunting (chronic malnutrition) but is not severe enough to raise significant concern. The appropriate intervention for moderate acute malnutrition is enrollment in a supplementary feeding program with fortified blended foods or small quantity lipid-based nutrient supplements, rather than the therapeutic feeding with RUTF required for SAM. Regular follow-up should be scheduled to monitor progress and prevent deterioration to severe acute malnutrition.",
      "correct_choice_id": 205427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59382,
      "choices": [
        {
          "id": 205430,
          "text": "ORS containing 90 mEq/L sodium, 80 mEq/L chloride, 20 mEq/L potassium, 111 mmol/L glucose, with total osmolarity of 310 mOsm/L; administered at 75 mL/kg over 8 hours"
        },
        {
          "id": 205431,
          "text": "ORS containing 75 mEq/L sodium, 65 mEq/L chloride, 20 mEq/L potassium, 75 mmol/L glucose, with total osmolarity of 245 mOsm/L; administered at 75 mL/kg over 4 hours"
        },
        {
          "id": 205432,
          "text": "ORS containing 45 mEq/L sodium, 40 mEq/L chloride, 20 mEq/L potassium, 55 mmol/L glucose, with total osmolarity of 210 mOsm/L; administered at 50 mL/kg over 4 hours"
        },
        {
          "id": 205433,
          "text": "ORS containing 75 mEq/L sodium, 65 mEq/L chloride, 20 mEq/L potassium, 75 mmol/L glucose, with total osmolarity of 245 mOsm/L; administered at 50-100 mL after each diarrheal stool"
        }
      ],
      "text": "An 18-month-old boy presents to a rural health center with a 3-day history of watery diarrhea (6-8 episodes daily) and vomiting (2-3 times daily). On examination, he appears restless, has sunken eyes, drinks eagerly when offered fluids, and his skin pinch returns slowly (about 2 seconds). The healthcare worker determines the child has some dehydration according to WHO guidelines and prepares to administer oral rehydration solution. Which of the following correctly describes the WHO-recommended low osmolarity ORS composition and dosing for this child?",
      "unique_key": "Q7467630",
      "question_audio": null,
      "question_video": null,
      "map_id": 34373746,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nORS containing 75 mEq/L sodium, 65 mEq/L chloride, 20 mEq/L potassium, 75 mmol/L glucose, with total osmolarity of 245 mOsm/L; administered at 75 mL/kg over 4 hours\r\n\r\nExplanation: WHO recommends low osmolarity ORS with a composition of 75 mEq/L sodium, 65 mEq/L chloride, 20 mEq/L potassium, 75 mmol/L glucose, and a total osmolarity of 245 mOsm/L. This formulation replaced the previous standard ORS (311 mOsm/L) in 2002 after clinical trials demonstrated reduced need for IV fluids, decreased vomiting, and lower stool output compared to the original formula. For a child with some dehydration (as in this case, based on WHO clinical criteria: restless/irritable, sunken eyes, drinks eagerly, skin pinch returns slowly), the recommended treatment is 75 mL/kg of ORS over 4 hours, followed by reassessment. Option A describes the old standard ORS formula with incorrect administration time. Option C describes an incorrect composition with inadequate sodium content. Option D describes the correct composition but the administration strategy for preventing dehydration (Plan A) rather than treating some dehydration (Plan B).",
      "correct_choice_id": 205431,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59383,
      "choices": [
        {
          "id": 205434,
          "text": "10 mg elemental zinc daily for 10-14 days"
        },
        {
          "id": 205435,
          "text": "20 mg elemental zinc daily for 10-14 days"
        },
        {
          "id": 205436,
          "text": "5 mg elemental zinc daily for 5-7 days"
        },
        {
          "id": 205437,
          "text": "20 mg elemental zinc twice daily for 3-5 days"
        }
      ],
      "text": "A 3-year-old girl weighing 12 kg presents with acute watery diarrhea of 2 days' duration. She has no signs of dehydration but continues to have 4-5 loose stools daily. The physician explains to the mother that in addition to maintaining hydration and continuing age-appropriate feeding, zinc supplementation is recommended as part of the WHO diarrhea management protocol. What is the correct zinc supplementation regimen for this child according to WHO guidelines?",
      "unique_key": "Q8517838",
      "question_audio": null,
      "question_video": null,
      "map_id": 34692478,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\n20 mg elemental zinc daily for 10-14 days\r\n\r\nExplanation: The WHO and UNICEF recommend zinc supplementation as part of the treatment protocol for acute diarrhea in children. For children aged 6 months and older, the recommended dose is 20 mg of elemental zinc daily for 10-14 days, regardless of the type of diarrhea (acute watery, dysentery, or persistent). For infants under 6 months, the recommended dose is 10 mg daily for 10-14 days. The complete 10-14 day course should be administered even if diarrhea resolves earlier, as continued supplementation reduces the incidence of diarrhea in the following 2-3 months. Zinc supplementation has been shown to reduce the duration and severity of diarrheal episodes, stool volume, and the need for advanced medical care. It also prevents future episodes for 2-3 months by helping restore intestinal mucosal integrity and enhancing immune function. Options A, C, D, and E all represent incorrect dosing, duration, or both for this 3-year-old child",
      "correct_choice_id": 205435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59384,
      "choices": [
        {
          "id": 205438,
          "text": "Tetralogy of Fallot with pulmonary atresia"
        },
        {
          "id": 205439,
          "text": "Transposition of the great arteries with intact ventricular septum"
        },
        {
          "id": 205440,
          "text": "Total anomalous pulmonary venous return below the diaphragm"
        },
        {
          "id": 205441,
          "text": "Tricuspid atresia with ventricular septal defect"
        }
      ],
      "text": "A 2-month-old infant is brought to the pediatric emergency department with progressive cyanosis and respiratory distress. The baby was born at term with no perinatal complications and was discharged home on day 3 of life. Parents report poor feeding, diaphoresis during feeds, and increasing bluish discoloration of lips and extremities over the past week. On examination, the infant has central cyanosis, tachypnea (respiratory rate 65/min), moderate subcostal retractions, and hepatomegaly (liver edge palpable 4 cm below costal margin). Cardiac examination reveals hyperdynamic precordium with a loud single S2. The oxygen saturation is 72% in room air and does not improve significantly with 100% oxygen (increases to 78%). Complete blood count shows polycythemia with hemoglobin of 18.5 g/dL. Which of the following congenital heart defects most likely explains this infant's presentation of cyanosis with plethora?",
      "unique_key": "Q5458879",
      "question_audio": null,
      "question_video": null,
      "map_id": 34330239,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nTotal anomalous pulmonary venous return below the diaphragm\r\n\r\nExplanation: This infant presents with the classic triad of cyanosis, pulmonary overcirculation (plethora), and congestive heart failure—a pattern typically seen in cyanotic lesions with increased pulmonary blood flow. Total anomalous pulmonary venous return (TAPVR), particularly the infracardiac (below diaphragm) type, best fits this clinical picture. In TAPVR, pulmonary veins drain anomalously to the systemic venous circulation rather than to the left atrium, creating an obligatory right-to-left shunt at the atrial level through a patent foramen ovale. The infracardiac type often involves obstruction of the anomalous venous channel, leading to pulmonary venous hypertension, pulmonary edema, and severe cyanosis that responds poorly to oxygen supplementation. The combination of pulmonary venous obstruction with pulmonary overcirculation creates the picture of \"cyanosis with plethora.\" Other cyanotic lesions like Tetralogy of Fallot, tricuspid atresia, and critical pulmonary stenosis typically present with decreased pulmonary blood flow (oligemia), not plethora. Transposition of great arteries can present with cyanosis and plethora but usually has better oxygenation in the newborn period due to mixing through PDA and PFO, and heart failure typically develops later.",
      "correct_choice_id": 205440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59385,
      "choices": [
        {
          "id": 205442,
          "text": "Immediate endotracheal intubation, followed by propranolol administration and preparation for emergency total corrective surgery"
        },
        {
          "id": 205443,
          "text": "Knee-chest position, oxygen administration, IV fluid bolus, morphine sulfate (0.1-0.2 mg/kg IV), followed by propranolol if needed"
        },
        {
          "id": 205444,
          "text": "Rapid administration of sodium bicarbonate, epinephrine, and atropine, followed by ECMO if persistent hypoxemia"
        },
        {
          "id": 205445,
          "text": "Immediate administration of prostaglandin E1 infusion, followed by balloon atrial septostomy"
        }
      ],
      "text": "A 9-month-old boy with known Tetralogy of Fallot awaiting corrective surgery presents to the emergency department with an acute episode of intense cyanosis, irritability, and hyperpnea that began during feeding. The mother reports the infant became extremely blue, agitated, and developed labored breathing. On examination, the child is markedly cyanotic with oxygen saturation of 55%, heart rate 180/min, respiratory rate 60/min, and appears lethargic. This is his third such episode in the past week, with each episode becoming progressively more severe and prolonged. Which sequence of interventions is most appropriate in the immediate management of this hypercyanotic spell?",
      "unique_key": "Q2762194",
      "question_audio": null,
      "question_video": null,
      "map_id": 34515857,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B)\r\n\r\nKnee-chest position, oxygen administration, IV fluid bolus, morphine sulfate (0.1-0.2 mg/kg IV), followed by propranolol if needed\r\n\r\nExplanation: This child is experiencing a classic hypercyanotic (\"tet\") spell—a paroxysmal episode of hypoxemia in patients with Tetralogy of Fallot caused by acute increase in right-to-left shunting across the ventricular septal defect due to increased right ventricular outflow tract (RVOT) obstruction and/or decreased systemic vascular resistance. The management follows a stepwise approach aimed at decreasing RVOT obstruction, increasing systemic vascular resistance, and breaking the cycle of hypoxemia and acidosis:\r\n\r\nPlace the child in knee-chest position to increase systemic vascular resistance\r\nAdminister 100% oxygen to maximize pulmonary blood oxygen content\r\nGive IV fluid bolus (10-20 mL/kg) to increase preload and cardiac output\r\nAdminister morphine sulfate (0.1-0.2 mg/kg IV/IM/SC) to reduce hyperpnea and provide sedation\r\nConsider phenylephrine or other alpha-adrenergic agents to increase systemic vascular resistance\r\nUse beta-blockers (propranolol 0.1-0.2 mg/kg IV slowly) if the spell persists to reduce right ventricular infundibular spasm\r\n\r\nFor recurrent or severe spells, medical treatment with propranolol and urgent surgical correction should be considered. Intubation may worsen the spell due to increased catecholamines from stress. Prostaglandin E1 is indicated for ductal-dependent lesions, not TOF. ECMO would be a last resort for refractory hypoxemia. Albuterol may worsen the spell through beta-adrenergic stimulation decreasing systemic vascular resistance.",
      "correct_choice_id": 205443,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59386,
      "choices": [
        {
          "id": 205446,
          "text": "Marked decrease in oxygen saturation, respiratory alkalosis, decreased hemoglobin, and new onset of holosystolic murmur"
        },
        {
          "id": 205447,
          "text": "Sudden increase in oxygen saturation, metabolic acidosis, and disappearance of the systolic murmur"
        },
        {
          "id": 205448,
          "text": "Marked decrease in oxygen saturation, metabolic acidosis, narrowed pulse pressure, and diminution or disappearance of the systolic murmur"
        },
        {
          "id": 205449,
          "text": "Mild decrease in oxygen saturation with increased intensity of systolic murmur and prominent right ventricular heave"
        }
      ],
      "text": "A 6-month-old girl is referred to pediatric cardiology for evaluation of suspected congenital heart disease. The parents report episodes of increasing bluish discoloration, especially during crying and feeding, that have become more frequent over the past month. During these episodes, they notice the baby becomes irritable, breathes rapidly, and sometimes becomes limp afterward. On examination, the infant has a grade 3/6 harsh systolic ejection murmur at the left upper sternal border, oxygen saturation of 85% at rest, and mild clubbing of fingers and toes. An echocardiogram confirms the diagnosis of Tetralogy of Fallot with moderate-to-severe pulmonary stenosis. Which constellation of clinical and laboratory findings during an acute episode would most specifically confirm the diagnosis of a hypercyanotic spell in this infant?",
      "unique_key": "Q6469384",
      "question_audio": null,
      "question_video": null,
      "map_id": 34402313,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nMarked decrease in oxygen saturation, metabolic acidosis, narrowed pulse pressure, and diminution or disappearance of the systolic murmur\r\n\r\nExplanation: A hypercyanotic (\"tet\") spell in Tetralogy of Fallot presents with characteristic clinical and laboratory features that reflect the underlying pathophysiology of acute, severe right-to-left shunting:\r\n\r\nMarked cyanosis with precipitous drop in oxygen saturation (often to <60%) due to increased right-to-left shunting across the VSD\r\nMetabolic acidosis (not respiratory alkalosis) from tissue hypoxia and anaerobic metabolism\r\nDiminution or disappearance of the pulmonary outflow tract murmur as the right ventricular infundibular spasm worsens, reducing flow across the pulmonary valve\r\n\r\nNarrowed pulse pressure from compensatory peripheral vasoconstriction\r\nHyperpnea (rapid, deep breathing) as a compensatory mechanism for acidosis\r\nIncreased irritability followed by lethargy as hypoxemia persists\r\n\r\nThese episodes are typically triggered by activities that increase oxygen demand or decrease systemic vascular resistance (crying, feeding, defecation, bathing) or increase catecholamines (pain, fever). The diagnosis is primarily clinical during an acute episode, though continuous pulse oximetry monitoring can document the precipitous drop in oxygen saturation. ECG during an attack may show signs of right ventricular strain or ischemia. Option A incorrectly describes respiratory alkalosis and a new holosystolic murmur. Option B incorrectly suggests increased oxygenation. Option D describes stable TOF without a spell. Option E incorrectly includes hypertension (hypotension would be more likely) and respiratory rather than metabolic acidosis.RetryClaude can make mistakes. Please double-check responses.",
      "correct_choice_id": 205448,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59387,
      "choices": [
        {
          "id": 205450,
          "text": "Levetiracetam monotherapy"
        },
        {
          "id": 205451,
          "text": "Topiramate with clobazam"
        },
        {
          "id": 205452,
          "text": "Hormonal therapy (ACTH or high-dose oral prednisolone)"
        },
        {
          "id": 205453,
          "text": "Ketogenic diet"
        }
      ],
      "text": "A 7-month-old previously healthy infant is brought to the pediatric neurology clinic with a 2-week history of clusters of brief, sudden flexion movements involving the neck, trunk, and arms. The parents report these episodes occur most commonly upon awakening, with 5-10 spasms occurring in clusters several times daily. There has been regression in developmental milestones over the past month, with loss of social smile and decreased visual tracking. EEG demonstrates hypsarrhythmia. MRI brain shows normal anatomy with delayed myelination. Which treatment option is most strongly recommended as first-line therapy for this infant's condition?",
      "unique_key": "Q6932844",
      "question_audio": null,
      "question_video": null,
      "map_id": 34162845,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nHormonal therapy (ACTH or high-dose oral prednisolone)\r\n\r\nExplanation: This infant presents with classic infantile spasms (West syndrome), characterized by the triad of epileptic spasms, developmental regression, and hypsarrhythmia on EEG. Infantile spasms represent an age-specific epileptic encephalopathy requiring urgent intervention to optimize neurodevelopmental outcomes. According to the American Academy of Neurology and Child Neurology Society guidelines, hormonal therapy (either adrenocorticotropic hormone [ACTH] or high-dose oral prednisolone) is recommended as first-line treatment with the strongest evidence base. These agents demonstrate superior efficacy in achieving both clinical spasm cessation and EEG normalization compared to conventional antiseizure medications, with response rates of 70-87%. Vigabatrin is an alternative first-line agent, particularly in tuberous sclerosis complex, but was not listed among the options. The conventional antiseizure medications listed (levetiracetam, topiramate, phenobarbital) have significantly lower efficacy as monotherapy for infantile spasms (generally <40% response rate). The ketogenic diet may be considered as adjunctive or later-line therapy but is not recommended as initial treatment. The goal of therapy is complete cessation of spasms and resolution of hypsarrhythmia, as persistent spasms are associated with worse neurodevelopmental outcomes.",
      "correct_choice_id": 205452,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59388,
      "choices": [
        {
          "id": 205454,
          "text": "Lamotrigine"
        },
        {
          "id": 205455,
          "text": "Carbamazepine"
        },
        {
          "id": 205456,
          "text": "Ethosuximide"
        },
        {
          "id": 205457,
          "text": "Phenytoin"
        }
      ],
      "text": "An 8-year-old girl is referred to your neurology clinic for evaluation of episodes of \"staring\" and \"daydreaming\" that have been occurring multiple times daily for the past 3 months. Her teacher reports that during these episodes, the child abruptly stops activity, stares blankly, and is unresponsive for approximately 10-15 seconds, after which she resumes activities as if nothing happened. She is not aware of these episodes and has no post-ictal confusion. Her academic performance has declined. Hyperventilation in the office triggers a typical episode. EEG demonstrates 3 Hz generalized spike-and-wave discharges during the episodes. Neurological examination and brain MRI are normal. Which antiseizure medication would be most appropriate as initial therapy for this patient?",
      "unique_key": "Q6470008",
      "question_audio": null,
      "question_video": null,
      "map_id": 34577945,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nEthosuximide\r\n\r\nExplanation: This patient presents with classic childhood absence epilepsy (CAE), characterized by frequent brief episodes of altered consciousness with 3 Hz generalized spike-and-wave discharges on EEG, often provoked by hyperventilation. Ethosuximide is considered the optimal first-line treatment for childhood absence epilepsy when absence seizures are the only seizure type present, based on the landmark Childhood Absence Epilepsy (CAE) trial and subsequent guidelines. Ethosuximide provides excellent seizure control (approximately 80% seizure freedom) with a more favorable cognitive and behavioral side effect profile compared to valproic acid. If the patient has concomitant generalized tonic-clonic seizures or myoclonic seizures (not present in this case), valproic acid would be preferred. Lamotrigine is an effective second-line agent for absence seizures but has a slower titration schedule and lower efficacy rate compared to ethosuximide. Carbamazepine and phenytoin are sodium channel blockers that can paradoxically worsen absence seizures and are contraindicated in this epilepsy syndrome. Clobazam may be effective as adjunctive therapy but is not typically used as first-line monotherapy for absence epilepsy due to issues with tolerance and cognitive side effects.",
      "correct_choice_id": 205456,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59389,
      "choices": [
        {
          "id": 205458,
          "text": "Valproic acid with folic acid supplementation, discussion of teratogenic risk, counsel to avoid alcohol and sleep deprivation, restriction from driving until seizure-free for state-mandated period"
        },
        {
          "id": 205459,
          "text": "Lamotrigine monotherapy, counsel about gradual dose titration, avoidance of severe sleep deprivation, and need for lifelong treatment regardless of seizure freedom"
        },
        {
          "id": 205460,
          "text": "Levetiracetam monotherapy, counsel about potential mood-related side effects, strict avoidance of alcohol and sleep deprivation, advise against driving until 6 months seizure-free"
        },
        {
          "id": 205461,
          "text": "Zonisamide monotherapy, counsel about need for regular hydration, weight monitoring, summer job modification due to decreased sweating, and avoidance of photic stimulation"
        }
      ],
      "text": "A 17-year-old female presents after experiencing her second generalized tonic-clonic seizure. Both seizures occurred within 30 minutes of waking. For the past 8 months, she has experienced brief, bilateral arm jerks predominantly in the morning, causing her to drop items. Her father had epilepsy in his youth that \"he outgrew.\" Initial EEG shows normal background with occasional 4-6 Hz polyspike-wave discharges. Sleep-deprived EEG demonstrates photoparoxysmal response at 15-20 Hz stimulation and frequent generalized polyspike-wave discharges. She is a competitive high school student preparing for college applications and works part-time as a barista at a coffee shop with early morning shifts. She reports irregular sleep patterns and occasional recreational alcohol use at parties. Which management approach would BEST address both seizure control and this patient's specific circumstances?",
      "unique_key": "Q5941606",
      "question_audio": null,
      "question_video": null,
      "map_id": 34598316,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (C)</p>\r\n\r\n<p>Levetiracetam monotherapy, counsel about potential mood-related side effects, strict avoidance of alcohol and sleep deprivation, advise against driving until 6 months seizure-free Explanation: This is a complex JME case with several nuanced considerations that influence management decisions. While valproic acid remains most effective for JME (80-90% efficacy), its significant teratogenic risk makes it problematic as first-line therapy in a young woman of reproductive potential without a comprehensive contraception plan. Levetiracetam represents an appropriate alternative with good efficacy for JME (60-70%), rapid titration ability, minimal drug interactions, and no teratogenicity concerns. Critical aspects of management beyond medication choice include:</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Identification and avoidance of seizure precipitants specific to JME: The morning work schedule is problematic given that seizures in JME characteristically occur within 2 hours after awakening. Sleep deprivation and alcohol are powerful seizure triggers specific to JME and require strict avoidance.</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Counseling on medication effects: Levetiracetam&#39;s potential psychiatric side effects (irritability, mood changes) warrant monitoring in a student under academic pressure.</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Safety considerations: Driving restrictions must be implemented according to state regulations (typically 3-12 months seizure-free for epilepsy).</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Prognostic counseling: Unlike childhood absence epilepsy, JME requires lifelong treatment in most cases (&gt;90% relapse with discontinuation), and the family history of epilepsy that &quot;was outgrown&quot; may create false expectations.</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Lamotrigine (option B) can be effective but requires extremely slow titration (2-3 months) and may be less effective for myoclonic seizures. Carbamazepine and other sodium channel blockers (option E) are contraindicated in JME as they can worsen myoclonic and absence seizures. Zonisamide (option D) has limited evidence in JME as monotherapy.</span></span></p>\r\n",
      "correct_choice_id": 205460,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59390,
      "choices": [
        {
          "id": 205462,
          "text": "Tacrolimus is contraindicated due to the risk of nephrotoxicity in patients with FSGS"
        },
        {
          "id": 205463,
          "text": "Tacrolimus should be initiated with continued IV cyclophosphamide to achieve synergistic effects"
        },
        {
          "id": 205464,
          "text": "Tacrolimus monotherapy achieves approximately 70-80% complete or partial remission in children with steroid-resistant FSGS"
        },
        {
          "id": 205465,
          "text": "Tacrolimus is only indicated after rituximab failure in steroid-resistant nephrotic syndrome"
        }
      ],
      "text": "A 5-year-old boy presents with nephrotic syndrome characterized by edema, proteinuria (urine protein ratio 7.8 mg/mg), hypoalbuminemia (serum albumin 1.8 g/dL), and hypercholesterolemia (cholesterol 385 mg/dL). He was initially treated with oral prednisolone (2 mg/kg/day) for 6 weeks with no remission, followed by three IV methylprednisolone pulses (30 mg/kg) without improvement. Renal biopsy shows focal segmental glomerulosclerosis (FSGS). Genetic testing for FSGS-associated mutations is negative. His blood pressure is 110/75 mmHg (>95th percentile for age/height), and eGFR is 95 mL/min/1.73m². Which statement about the use of tacrolimus in this patient's condition is most accurate?",
      "unique_key": "Q5924753",
      "question_audio": null,
      "question_video": null,
      "map_id": 34213518,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nTacrolimus monotherapy achieves approximately 70-80% complete or partial remission in children with steroid-resistant FSGS\r\n\r\nExplanation: This patient has steroid-resistant nephrotic syndrome (SRNS) with biopsy-proven FSGS, one of the most challenging forms of childhood nephrotic syndrome. Tacrolimus (a calcineurin inhibitor) is a recommended second-line therapy for non-genetic SRNS after failure of standard steroid therapy. Multiple studies have demonstrated that tacrolimus monotherapy achieves complete or partial remission in approximately 70-80% of children with steroid-resistant FSGS, making it one of the most effective therapeutic options. The mechanism involves immunomodulation and stabilization of podocyte cytoskeleton through non-immunologic effects. Tacrolimus is typically administered at a starting dose of 0.1-0.2 mg/kg/day divided twice daily, with target trough levels of 5-10 ng/mL in the first 6 months and 3-7 ng/mL thereafter. While tacrolimus has nephrotoxic potential, this risk is manageable with appropriate monitoring of drug levels, renal function, and blood pressure. Combined therapy with cyclophosphamide is not standard practice and increases toxicity. Rituximab is not established as a therapy that must precede tacrolimus. Tacrolimus is effective in both minimal change disease and FSGS, though response rates are generally higher in minimal change disease.",
      "correct_choice_id": 205464,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59391,
      "choices": [
        {
          "id": 205466,
          "text": "Oral cyclophosphamide should be administered at 2-3 mg/kg/day for 8-12 weeks with a maximum cumulative dose of 168 mg/kg"
        },
        {
          "id": 205467,
          "text": "Oral cyclophosphamide induces long-term remission in approximately 30-40% of steroid-dependent nephrotic syndrome cases"
        },
        {
          "id": 205468,
          "text": "Cyclophosphamide is contraindicated in pre-pubertal females due to gonadal toxicity"
        },
        {
          "id": 205469,
          "text": "Cyclophosphamide therapy requires concurrent high-dose steroid administration (2 mg/kg/day) throughout the treatment period"
        }
      ],
      "text": "An 8-year-old girl with frequently-relapsing, steroid-dependent nephrotic syndrome has been continuously on steroids for 2.5 years, with multiple relapses occurring during tapering. Her current maintenance dose is prednisolone 0.5 mg/kg on alternate days. She has developed significant steroid toxicity including cushingoid features, growth retardation (height <3rd percentile), hypertension, glucose intolerance, and posterior subcapsular cataracts. Previous attempts with levamisole were unsuccessful. Her kidney function is normal with eGFR 110 mL/min/1.73m². Renal biopsy performed one year ago showed minimal change disease. Which of the following statements regarding oral cyclophosphamide therapy is most accurate for this patient?",
      "unique_key": "Q1882372",
      "question_audio": null,
      "question_video": null,
      "map_id": 34691794,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A)  \r\n\r\nOral cyclophosphamide should be administered at 2-3 mg/kg/day for 8-12 weeks with a maximum cumulative dose of 168 mg/kg\r\n\r\nExplanation: This patient has frequently-relapsing, steroid-dependent nephrotic syndrome with significant steroid toxicity, making her an appropriate candidate for steroid-sparing therapy. Oral cyclophosphamide is a well-established second-line agent for such cases. The recommended protocol for oral cyclophosphamide is 2-3 mg/kg/day for 8-12 weeks (typically 12 weeks) with a maximum cumulative dose of 168 mg/kg to minimize toxicity while maximizing efficacy. This finite course offers the advantage of treatment completion rather than indefinite therapy. The sustained remission rate after cyclophosphamide in steroid-dependent nephrotic syndrome is approximately 60-65% at 2 years, not 30-40%. While gonadal toxicity is a concern, it is dose-dependent and significantly higher with prolonged treatment or multiple courses. A single 12-week course is considered acceptable in both males and females when benefits outweigh risks. During cyclophosphamide treatment, steroids are typically maintained at moderate doses (1 mg/kg alternate days or less) and gradually tapered, not high-dose throughout. Extending cyclophosphamide beyond 12 weeks increases toxicity without proportional efficacy benefit. Important monitoring during therapy includes weekly CBC for the first month then biweekly, urinalysis, and strict attention to hydration to prevent hemorrhagic cystitis.",
      "correct_choice_id": 205466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59392,
      "choices": [
        {
          "id": 205470,
          "text": "Typical (Shiga toxin-associated) hemolytic uremic syndrome"
        },
        {
          "id": 205471,
          "text": "Atypical hemolytic uremic syndrome"
        },
        {
          "id": 205472,
          "text": "Thrombotic thrombocytopenic purpura"
        },
        {
          "id": 205473,
          "text": "Disseminated intravascular coagulation"
        },
        {
          "id": 205474,
          "text": "Autoimmune hemolytic anemia with Evans syndrome"
        }
      ],
      "text": "A previously healthy 4-year-old boy presents to the emergency department with a 3-day history of pallor, irritability, and decreased urine output. There is no preceding diarrheal illness or upper respiratory symptoms. On examination, he has periorbital edema, petechiae on extremities, BP 140/95 mmHg (>99th percentile), and no neurological deficits. Laboratory studies reveal: hemoglobin 6.2 g/dL, platelets 45,000/μL, peripheral smear with numerous schistocytes, reticulocytes 8%, serum creatinine 2.1 mg/dL (baseline unknown), LDH 1850 U/L (elevated), haptoglobin <10 mg/dL, normal PT/PTT, and negative direct Coombs test. Urinalysis shows 3+ protein and 3+ blood. Stool culture and Shiga toxin testing are negative. Further workup reveals C3 80 mg/dL (mildly decreased, normal 90-180), C4 normal, and ADAMTS13 activity 68% (normal). Which is the most likely diagnosis in this patient?",
      "unique_key": "Q6383265",
      "question_audio": null,
      "question_video": null,
      "map_id": 34147408,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p>Correct Answer (B)</p>\r\n\r\n<p>Atypical hemolytic uremic syndrome</p>\r\n\r\n<p>Explanation: This case presents the classic triad of microangiopathic hemolytic anemia (anemia with schistocytes), thrombocytopenia, and acute kidney injury characteristic of thrombotic microangiopathy (TMA). The absence of preceding diarrhea or positive Shiga toxin argues against typical HUS. The diagnosis of atypical HUS (aHUS) is supported by:</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Absence of Shiga toxin-producing E. coli infection or other typical HUS triggers</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Normal ADAMTS13 activity (ruling out TTP, which typically has activity &lt;10%)</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Evidence of complement dysregulation (mildly decreased C3 with normal C4)</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Negative Coombs test (ruling out immune-mediated hemolysis)</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Absence of coagulopathy (normal PT/PTT would be abnormal in DIC)</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Atypical HUS is a rare, genetic or acquired disorder of alternative complement pathway dysregulation, often presenting with more severe kidney injury and worse prognosis than typical HUS. While genetic testing for mutations in complement regulatory proteins (CFH, CFI, MCP, C3, CFB) and antibodies against Factor H would be warranted, the clinical and laboratory features strongly suggest aHUS. Immediate recognition is critical as treatment with complement inhibition (eculizumab) significantly improves outcomes. Typical HUS usually follows diarrheal illness with Shiga toxin. TTP presents similarly but requires severe ADAMTS13 deficiency. DIC would show abnormal coagulation studies. Autoimmune hemolytic anemia would have positive Coombs test and lack the TMA features.</span></span></p>\r\n",
      "correct_choice_id": 205471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59393,
      "choices": [
        {
          "id": 205475,
          "text": "Eculizumab treatment should be deferred until complete platelet recovery (>150,000/μL) is achieved with plasma exchange"
        },
        {
          "id": 205476,
          "text": "Meningococcal vaccines (MenACWY and MenB) should be administered at least 2 weeks before initiating eculizumab, with no need for prophylactic antibiotics if properly vaccinated"
        },
        {
          "id": 205477,
          "text": "Eculizumab therapy targets C5 complement, blocking formation of membrane attack complex, and should be initiated promptly with appropriate meningococcal prophylaxis"
        },
        {
          "id": 205478,
          "text": "Eculizumab is contraindicated in patients with mutations in complement regulators as it may accelerate complement consumption"
        }
      ],
      "text": "A 7-year-old girl is diagnosed with atypical hemolytic uremic syndrome (aHUS) after presenting with microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury requiring dialysis. Genetic testing reveals a heterozygous mutation in complement factor H (CFH). After five plasma exchange sessions with minimal improvement, eculizumab therapy is being considered. Her immunization status is up-to-date according to the standard schedule, but she has not received any additional vaccines. Current lab values: hemoglobin 7.8 g/dL, platelets 80,000/μL, creatinine 3.2 mg/dL, LDH 1200 U/L. Which of the following statements is most accurate regarding eculizumab therapy for this patient?",
      "unique_key": "Q6420309",
      "question_audio": null,
      "question_video": null,
      "map_id": 34163901,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C)\r\n\r\nEculizumab therapy targets C5 complement, blocking formation of membrane attack complex, and should be initiated promptly with appropriate meningococcal prophylaxis\r\n\r\nExplanation: Eculizumab is a humanized monoclonal antibody that binds to complement protein C5, preventing its cleavage into C5a and C5b, thereby inhibiting formation of the membrane attack complex (C5b-9) that drives the pathophysiology of atypical HUS. For this patient with CFH mutation-confirmed aHUS and ongoing evidence of TMA despite plasma exchange, eculizumab is the treatment of choice and should be initiated promptly rather than delaying until complete hematologic normalization. The FDA has approved eculizumab for both pediatric and adult patients with aHUS.\r\n\r\nKey management considerations for eculizumab include:\r\n\r\nInfectious risk: Eculizumab significantly increases susceptibility to meningococcal infections. Ideally, meningococcal vaccines (both MenACWY and MenB) should be administered at least 2 weeks before starting therapy. However, in patients requiring urgent treatment, vaccination should proceed concurrent with initiation of therapy, and prophylactic antibiotics (usually penicillin or amoxicillin) should be provided for at least 2 weeks post-vaccination and potentially throughout therapy depending on risk assessment.\r\nDosing: Weight-based dosing in pediatric patients, with an initial loading phase followed by maintenance therapy.\r\nMonitoring: Regular assessment of hematologic parameters, renal function, and complement blockade (CH50).\r\nDuration: Often continued indefinitely, though some protocols allow consideration of discontinuation after 6-12 months in selected patients with careful monitoring.\r\n\r\nThe evidence for efficacy is strongest in patients with identified complement mutations (as in this case), not contraindicated. Delaying therapy while awaiting complete normalization with plasma exchange is not recommended given the superior efficacy of eculizumab in complement-mediated aHUS.",
      "correct_choice_id": 205477,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}